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Abstract 
There is currently much interest in the use of pulse contour analysis in 
studying vascular structure and function. The usual approach is to record the 
radial pressure pulse non-invasively, to apply a transfer function to estimate the 
aortic pressure pulse, and then to derive the aortic augmentation index (Alx), an 
index of arterial tone and stiffness. Whereas the transfer function allows a good 
estimation of aortic systolic blood pressure, this thesis shows that its accuracy in 
estimating AIx remains questionable. Furthermore, transforming the radial pulse 
to the aortic pulse may not be necessary, as similar information is present in the 
peripheral pulse. Measurement of infra-red light transmission through the finger 
pulp to obtain a digital volume pulse (DVP) provides a particularly simple means 
of obtaining a peripheral pulse. The contour of the DVP has hitherto been 
analysed in ten-ns of 2d derivative indices. These are influenced by ageing and 
vasoactive drugs but their physical meaning is not clear. This thesis shows that 
the contour of the DVP (in contrast to its amplitude which is influenced by local 
perfusion) is closely related to that of the pressure pulse, and can be interpreted 
as the summation of a direct and reflected wave. A reflection index (RI) has been 
defined to quantify the degree of wave reflection sensitive to drug induced 
change in arterial tone. Timing of the reflected wave relative to the direct wave is 
determined by pulse wave velocity in the large arteries and allows an index of 
large artery stiffness (SI) to be estimated from the DVP. Comparison of RI and 
SI with 2 nd derivative indices suggests that, at least in healthy subjects, RI 
performs better in tracking effects of vasoactive drugs on arterial tone, and SI 
correlates better with age and blood pressure, and is thus likely to be a better 
index of vascular ageing. Clinical studies show that contour analysis of the DVP 
can be used to assess endothelial function and to study vascular structure and 
function in pregnancy and in relation to birth weight. 
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CHAPTER 1: Introduction 
17 
Interest in the mechanical properties of arteries commenced with clinical 
examination of the arterial pulse, which has been used as a diagnostic aid since 
ancient times. Quantitative attempts to measure the form of the arterial pulse 
were made as long ago as 1860. In the early 1900s, it was appreciated that the 
elasticity of the arterial wall governs the speed of pressure wave propagation 
(P'vW) providing a method for measuring arterial compliance. In the mid- 
twentieth century, photoelectric techniques based on the absorption of infra-red 
light by red-blood cells were used to recorded a simple volume pulse. With 
modem instrumentation, and the appreciation of the clinical importance of 
physical properties of arteries there has been a resurgence of interest in the 
application of non-invasive techniques based on pulse wave analysis to assess 
arterial structure and function. 
1.1 Arterial pressure pulse 
For a long time, the only way to assess the pulse was by feeling it and 
there was no way of measuring it quantitatively. It was only in 1860 that the first 
quantitative recording of the arterial pulse was made. Etienne Jules Marey 
developed a mechanical "sphygrnogram", which reproduced the arterial pulse 
waveform on a paper display. 
18 
I-- 
figure 1: Mechanical sphygmogram developed by EJ Marey. 
The waveform is directly plotted onto smokedpaper, moved by a clock-work mechanism. 
82-84 The sphygmogram was used by English clinicians such as Mahomed 
Broadbent22 and Mackensie 79 at the turn of the nineteenth century. They wrote 
articles about the interpretation of the shape of the pulse for diagnosing clinical 
hypertension. Mahomed, for example, accurately described how the pulse 
waveforin changes with age 83 and blood pressure 82 . At a time when ECGs and 
X-rays were not in clinical use, Mackensie was using the sphygmogram as a 
standard tool in assessing diseases and studying the response to treatment. In 
1879, in studies published in the Lancet, Murrell used the sphygmogram to 
describe the alterations of the radial pressure pulse after amyl nitrite and glyceryl 
trinnitrate 98-101 (see figure 2). 
However, the technique remained difficult to implement and the 
interpretation of the pulse shape was far from easy. With the introduction of 
sphygmomanometer by Riva-Rocci and Korotkov in the early 1900s, which 
enabled systolic and diastolic pressure to be measured, interest in the shape of the 
pulse disappeared. A renewed interest came with the introduction of new 
technology, recording apparatus and signal processing. It is now possible to 
measure the arterial pulse accurately and easily and to use all the information 
contained within the pressure pulse. 
19 
Nitrite of Arnyl on Poisr. 
figure 2. - Chan es of the radial pressure pulse after inhalation of amyl nitrite 9 
from the Lancet 187999 
Independently of the sphygmograph, much work was done in the early 
20th century to interpret the arterial pulse. Otto FrancOo in 1899 introduced the 
Windkessel model to explain the pattern of the pressure pulse. It assumes that 
flow from a pump (the heart) enters an elastic chamber (arteries) through a one 
20 
way valve (the aortic valve), entering more rapidly than it can leave by way of a 
narrow exit tube (representing resistance vessels) that impedes outflow. 
FA 
Rp 
figure 3. - Windkessel model 
Rc is the characteristic resistance of the arterial tree. 
C is its compliance and Rp its peripheral resistance. 
PA is the aortic pressure and FA the aorticflow. 
The Windkessel model is still used as a simple model to explain the basic 
shape of the pressure pulse and the damping process of the pressure waves within 
the arterial tree 
3 1; 39; 88; 154 
. However, it fails to take into account the reflection 
phenomena explained by McDonald'04 , Womersley 
152 and Taylor 87 . Womersley 
showed that the arterial system behaves as a linear system 152 in which Fourier 
decomposition can be used to separate pressure and flow waveforms into their 
constituent hannonics. This work pen-nitted the study of pressure waves and the 
input impedance of the arterial tree. The study of the Fourier decomposition of 
pressure waves at difference sites along the aorta animals such as rabbits, dogs 
and wombats (figure 4) and in humans, shows a progressive increase in the 
amplitude of the harmonics towards peripheral vessels suggesting the presence of 
a reflection site' 04; 109. Fluctuations of the input impedance agree with the 
presence of a reflection site in the lower body. 
21 











20 mmHg I 
DiSlance from aortic valve(cm) 
I -j 0.5 sec 
O'Rourke, 1967 
figure 4: Aortic pressure in a wom bat aorta' 09 
recorded at increasing distancesfrom the aortic valve. 
There is a progressive delay of thefoot of the waveform due to thefinite speed ofpressure 
propagation in the elastic aorta. The diastolic reflected component of the waveform (at distances 
greater than 25cmfrom the aortic valve where it is clearly separatedfrom the systolic 
component) can be observed travelling in the opposite direction. 
These data are in favour of propagation and reflection of pressure waves 
in the arterial tree fort-ning the arterial pulse. Using the theory of wave 
propagation in elastic tubes, Avolio 6, inspired by the work of Taylor' 35 , 
designed 
a computer model of the systemic circulation consisting of multiple branching 
elastic tubes. In models proposed by Avolio 6, and later by Karamanoglu et 
al. 56; 57 , the arterial tree was 
divided into tubes each defined by its length, its 
Young's modulus (which is its elasticity), its attenuation coefficient and 
reflection coefficient. Their computer models give an aortic impedance 
22 
approximation similar to measured valueS6; 
56. When a flow wave is used as input, 
the models give a good approximation of the pressure pulse 56 . These models 
provide evidence in favour of numerous reflected waves generated at the 
termination of each arterial branch. All these reflected waves summate and, when 
viewed from a point far from the reflective sites, can be interpreted as a single 
reflected wave. 
Viewed from the heart, there are 2 apparent reflection sites, one in the 
lower body, and one in the upper body. O'Rourke introduced the asymmetric T- 
tube model to describe these 2 reflection sites'09; 110 (figure 5). When the heart 
beats, it generates a direct pressure pulse, which travels forward in the arterial 
tree. At various points in the arterial tree, resistance and capacitance vary to 
create points of impedance mismatch. These points produce reflected waves, 
which travel back in the arterial tree and summate with the direct wave. The 
pressure pulse at any point of the arterial tree is hence the summation of a direct 
wave and reflected waves from the periphery. 
Differences in the timing and amplitude of reflected waves will alter the 
pressure pulse contour, and explain the difference in the pressure pulse contour 
measured at different site. The shape of pressure pulse can hence be used to 
improve the understanding of the arterial system. Indices have been derived from 
the pressure pulse, such as the augmentation index described in further detail in 
section 3.1.1, to quantify changes in the arterial pulse associated with ageing, 






lower body - 
reflection site 
figure 5. - T-tube model 
1/3 
2/3 
1.2 Vascular function and the arterial wall 
The arterial pulse is created by the heart ejecting blood into the arterial 
tree. This discontinuous ejection of blood is transfonned into a pulsatile but 
continuous flow in the peripheral arteries and in the capillaries where gas and 
nutnent exchange can occur. The aorta and other large conduit arteries act as a 
transporting and cushioning system of the arterial pulse (described as the 
Windkessel effect in section 1.1). 
The arterial wall consists of a layer of endothelial cells lining the lumen 
surrounded by smooth muscle cells arranged circularly and embedded in elastin 
and collagen fibres. The endothelial cells act as a barrier to plasma proteins and 
secretes numerous chemical mediators, which control the vasodilation/ 
24 
contraction of the smooth muscle cells. The aorta, iliac arteries and other major 
branches are referred to as elastic arteries. They perfon-n most of the cushioning 
function (the Windkessel effect) and hence are very distensible and rich in elastin 
fibres. Degenerative changes in elastin occur with age leading to a stiffening of 
elastic arteries, a process that may be accelerated by hypertension and other risk 
factors for vascular diseases. These alterations causes the arterial pulse wavefonn 
to change with ageing 62 . The wall of the muscular arteries (such as the radial and 
tibial arteries) contains more smooth muscle cells and is much thicker than the 
elastic arteries compared to their lumen. Together with the resistance vessels, the 
muscular arteries have a rich autonomic nerve supply and can contract or relax to 
regulate downstream blood flow. These changes in vascular tone alter wave 
reflections influencing the shape of the arterial pulse 59 . 
Over the last two decades it has been realised that the release of 
mediators from endothelial cells plays an important role in the 
relaxation/contraction of the underlying smooth muscles. Nitric oxide (NO) is 
51-114 
probably the most important endothelium derived vasodilator ,. It has 
received particular attention as, in addition to the regulation of vascular tone, it 
has anti-atherogenic actions. These include inhibition of adhesion molecules, 
inhibition of platelet adhesion and aggregation and inhibition of vascular smooth 
muscle proliferation 93 .A decrease 
in the availability of NO is thought to 
underlie much cardiovascular disease' 02 . There has thus been much 
interest in the 
idea that endothelium dependent vasodilation mediated by NO can be used to test 
for endothelial dysfunction predisposing to development of cardiovascular 
disease. An alteration in endothelium dependent vascular tone will influence the 
shape of the pulse wave. Pulse wave contour analysis coupled with an 
25 
appropriate endothelium dependent stimulus could therefore be used to test 
endothelium function. This idea is explored in section 8.1. 
1.3 Pulse wave velocity 
As shown in figure 4, the pressure pulse takes a finite time to propagate 
along the aorta. The velocity of propagation (PWV) was shown to be determined 
by the elastic modulus of the arterial wall by MoenS92 and Korteweg 66 at the end 
of the nineteen century. 
Moens-Korteweg equation: 
rEh 
r. p p 
PWV = ýr. D 
E: elastic modulus 
h: arterial wall thickness 
r: arterial radius 
p: blood viscosity 
In 1922, Bramwell and Hill modified this equation and expressed it as a 
change in arterial volume (AV) to variation of pressure (AP) as expressed by the 
Bramwell-Hill equation 21 PWV 
ARV 
p. AV 
An increase in aortic PV; V with age and blood pressure (BP) was 
recognised as early as 1934-1936 by Hallock 
43 and Haynes et al. 46 . This has 
been 
confinned by several authors and in particularly in a large rural and urban 
Chinese population where the presence of high salt diet and hypertension 
increased aortic pWV8,9 . Aortic 
PWV has received much recent interest because 
it has been found to be an independent predictor of cardiovascular events and/or 
26 
mortality. In 1999, Blacher et al. 17 reported that, in patients with end-stage renal 
disease, aortic PWV is a strong independent predictor of cardiovascular mortality 
and a better predictor of mortality than BP. In hypertensive patients, PWV was 
found to be significantly associated with the occurrence of coronary events and 
to predict these better than conventional Framingham risk factorS20. PWV was 
significantly associated in hypertensive patients with all-cause and 
cardiovascular mortality, independently of previous cardiovascular disease, age 
and diabeteS69. Meaume et al. 90 showed that aortic PVvrV is a strong independent 
predictor of cardiovascular death in patients aged more than 70 years of age with 
or without heart failure or history of stroke. In a 10 year follow up study, 
32 Cruickshank et al . 
found aortic PWV to be a powerful independent predictor of 
mortality in patients with diabetes and glucose intolerance. Because PWV is an 
independent predictor of cardiovascular risk, there is great interest in drugs that 
may improve aortic PWV. Conventional anti-hypertensive treatment may have a 
modest BP independent effect on pVýV2 . Among the 
different classes of anti- 
hypertensive drugs, ACE-inhibitors seems to produce the best improvement in 
4 
PVY'V independently of BP 
1.4 History and use of the Digital Volume Pulse 
In the 1930s, Alrick Hertzman 48 described a "photoelectric 
plethysmograph", a device which "takes advantage of the fact that the absorption 
of light by a transillurninated tissue varies with its blood contents". 
He described 
a device, which illuminated the skin and back-scattered 
light was measured by a 
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photocell (see figure 6, left panel). Robert GoetZ4 1 described a device measuring 
light transmitted through the finger (see figure 6, right panel). 
John Dillon and Alrick Hertzman 36 later described characteristics of the 
digital volume pulse (DVP) in normal subjects and patients with arterial disease. 
They described the shape of the DVP in terms of "crest time, the duration of the 
ascent of the primary wave" and "height of the incisura on the catacrotic limb" 
(figure 7). They observed a tendency of the incisura to rise with vasoconstriction 
(caused by immersing the opposite hand in water at 4'C) and an increase in the 
dicrotism (a decrease of the height of the incisura) during and shortly after amyl 
nitrite inhalation 36 . They described similar changes in the DVP to those observed 
by Murell in the radial pressure pulse after GTN98-101. They also compared the 
traces of normal subjects with those from subjects with hypertension or 
arteriosclerosis and found "an increase in the crest time, loss of the rebound wave 
and triangulation of the DVP"36 . However they 
did not quantify these changes, 




figure 6. - Mid-20'h century photoplethysmograph 
Left panel. - Hertzman's reflection photoplethysm ograph 48 
Rightpanel: Goetz's transmission photoplthysmograph" 





Later, in 1967ý Morikawa 94 used "a reflection photoelectric 
plethysmograph" to detect the effect of organic nitrates on the pulse wave. All 
the organic nitrate compounds altered the DVP in a similar way with a "decrease 
in the dicrotism" (see figure 8). Morikawa proposed the use of the DVP to detect 
the degree of nitrate poising in workers engaged in producing dynamite. During 
this investigation, he observed that alcohol produced the same change in 
"dicrotic index" of the DVP and suggested that the decrease in dicrotism was due 
to the vasodilator effects of nitrates and alcoho195 
figure 8: Measure of nitrate poising with photoplethysmography 
94 
figure 9: Morikawa's dicrotic index = bla 
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Later, in Europe, the previously described "dicrotic index" was used as a 
sensitive index of vasomotor effects of drugs particularly 
nitrates 
14; 23; 44; 78; 123; 128; 139; 140 
and also other vasodilators such as isoprenaline, 
89; 151 65; 128 sodium nitroprusside and nifedipine 
The early observations of Hertzman and Dillon about the alteration of the 
DVP in hypertensive subjects and patients with arteriosclerosis were confinned 
71 in a sub-study of the Framingham cohort. Lax et al. introduced a device they 
called a "vasculograph". This device measured pressure in a sensitive rubber cuff 
inside an inelastic backing applied around the finger, effectively providing a 
DVP 71 .T ey observed the presence of a "well-defined dicrotic wave" in healthy 
volunteers, whereas 98% of patients with clinical evidences of arteriosclerosis 
had a "diminution or disappearance of the dicrotic wave" 71 . Using the same 
34 
technique, Dawber et al. obtained the DVP in 1778 subjects recruited for the 
Framingham study during the period from 1965 to 1966. The DVP was 
characterised into 4 classeS34: 
Class I: "A distinct incisura is inscribed on the downward slope of the pulse 
wave" 
Class 2: "No incisura develops but the line of descent becomes horizontal" 
Class 3: "No notch is present but a well-defined change in the angle of the 
descent is observed" 
Class 4: "No evidence of a notch is seen" 
Like previous authors, they characterised the down-slope of the DVP. They 
found that a higher proportion of young subjects exhibited a class I DVP 
whereas class 4 DVP was mainly observed in older subjeCtS34. Patients diagnosed 
with coronary heart disease were more likely to exhibit a class 4 trace. 
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Multivariate logistic regression analysis for cardiovascular end-points occurring 
within 6 years, with age, systolic blood pressure and DVP classification as 




The DVP has also received much interest in Japan. Analysis there has 
centred on the second derivative of the DVP called the "acceleration 
photoplethysmograph". According to Takazawa et al. 
133 
, Takada et al. 
13 1 
and 
Imanaga et al. 52 , the acceleration photoplethysmogram has been employed 
instead of the DVP to facilitate the distinction of various components in the 
wavefonn. The acceleration photoplethysmogram (d 2 DVP/dt 2) typically 
comprises of 5 sequential waves called the a, b, c, d and e waves. The relative 
heights of these waves (b/a, c/a, d/a and e/a ratios), particularly the d/a ratio, have 
been related to age 




pWV45 and vasoactive drug effects' 
32 
. The 
b/a ratio has been related to ageing and carotid distensibility 52 . Following the 
results of the correlation of the b/a, c/a, d/a and e/a ratios with age, an ageing 
index has been defined as (b-c-d-e)/a 133 . Although the ageing 
index shows a 
45-133 pjW45. 
strong correlation with age , and BP, it is only weakly correlated with 
The second derivative of the DVP has been recently used to study arterial 
distensibility in adolescents and the d/a was proposed to identify individuals at an 
increase risk of developing atherosclerosis9l. 
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1.5 Purpose of this thesis 
Despite the interest in measurements derived from the contour of the 
arterial pulse, the interpretation of these remains controversial. This is 
particularly true for the DVP, the simplest and potentially most widely used test 
of vascular health. The purpose of this thesis is to examine the potential value of 
pulse contour analysis in the assessment of vascular function and structure both 
with respect to age, disease related changes and to phanuacological actions of 
vasoactive drugs. Following a discussion of methodology, the relationship 
between the peripheral pulse and the central aortic pulse is examined, as is the 
validity of the transfer function approach in estimating central aortic pressure 
from peripheral pressure. The relationship between the pressure pulse and the 
DVP is investigated. Indices characterising wave propagation and reflection 
derived from contour of the DVP are presented and compared with existing 
measurements derived from the second derivative of the DVP. Finally, clinical 
applications of the new DVP indices are discussed. 
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CHAPTER 2: Methods 
34 
2.1 Pressure pulse 
2.1.1 Applanation tonometry 
Applanation tonometry is a non-invasive technique for measuring arterial 
pressure. A piezo-resistive transducer is applied over an artery. When the piezo- 
electric crystal is deformed by arterial pressure transmitted through the overlying 
superficial tissue and skin, its resistance changes. This change in resistance is 
directly related to the pressure applied on the crystal. The piezoelectric 
transducer can be mounted on the tip of pen-type probe (Millar micro- 
manometer, Texas, US, figure 10 and figure 11) or an array of transducers can be 
strapped around the wrist (Colin wrist probe, Japan, figure 12). Applanation 
tonometry requires the artery to be flattened against a hard surface such as the 
head of the radial bone (radial artery) or the vertebral column and ligaments in 
the neck (carotid artery). It takes a little training to obtain optimal traces and, in 
obese patients when the artery is deep, it can be difficult to obtain satisfactory 
waveforms. Applanation tonometry has been validated and the radial artery 
pressure wavefonn obtained is very close to that obtained using invasive intra- 
arterial measurements of the radial artery pressure waveforM61 . Tonometer 
pressure and invasive pressure, when calibrated to shygmornanometric 
measurements of systolic and diastolic pressure, agree closely. When the 
spectrum of the waveform is examined, a small systemic difference is seen. The 
tonometer tends to overestimate the I't harmonic by 0.6mmHg and underestimate 
higher harmonics by no more than 0.4mmHg 61 
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figure 10: Tonometer (from Atcor website) 
figure 11: Tonometry technique (from Atcor website) 
figure 12: Colin wrist tonometer probe (from Colin website) 
36 
2.1.2 The digital pressure pulse 
A method to record the digital pressure pulse was introduced by Pefiaz 11 6 
and commercialised under the name of Finapres or Finometer (Finapres Medical 
system, Holland, figure 13). A cuff is inflated around the middle finger and a 
servo-controlled pump used to change the pressure inside the cuff to keep the 
amount of light passing through the finger constant. This method measures 




figure 13: Finapres (from Finapres website) 
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2.2 Digital Volume Pulse 
2.2.1 Oxymetry technique 
By transillurnimating tissue in the finger, one can measure the light 
absorption in the finger. This technique is widely used in oxymeter devices to 
determine oxygen saturation in the arterial blood. Oxygen saturation is measured 
from the ratio of absorbance of the red (usually 660 nm) and infra-red (usually 
940 nm) light, the red light being mainly absorbed by deoxyhemoglobin and the 
infra-red light by oxyhemoglobin. In the finger, blood from veins, venules, 
capillaries, arterioles, arteries and tissues absorbs light as shown in figure 14. 
The light absorbance can be divided into a constant component and a pulsating 
component, which gives the arterial volume pulse. Reduction in blood perfusion 
in the finger tip (for example in subjects with cold hands or Raynaud syndrome) 







figure 14. - Principle ofphotoplethysmography 
2.2.2 DVP probe 
arterial blood 
volume pulse" 
atile arterial blood 
ind capillary blood 
Of the 2 wavelengths used in pulse oxymetiy, infra-red light is absorbed 
most by the finger pulp, and provides the pulsatile signal of the greatest 
amplitude. For this reason the DVP was measured using a modified pulse 
oxymetry probe (Nellcor, California, US). It consists of an infra-red light 
emitting diode and a photodiode mounted on a finger clip as shown in figure 15. 
The pulsatile (AC component) part of the signal measured by the photodiode is 
the DVP. The signal from the photodiode was filtered and amplified and the DC 
component removed by an electronic circuit (Micro Medical Ltd, Gillingham, 
UK). 
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infra-red LED ""ý% 
figure 15: Schematic of a modifiedpulse oxymeter probe 





figure 16: Digital volume pulse probe 
2.2.3 DVP signal conditioning 
For studies in chapter 4,5 and 7, the signal from the modified Nellcor 
probe was sampled at I OOHz using a 12-bit analogue to digital acquisition board 
(PC30F Series Board of Eagle Technology) and stored on a PC using custom- 
built software. The software allowed continuous recording of the DVP waveform 
40 
photodiode 
for further analysis such as the calculation of the second derivative (chapter 7), 
transfer function (chapter 4) or indices characterising the contour of the pulse 
(see appendices). The algorithms described in appendix 10.1 to calculate the 
average pulse and the contour indices were first developed with Matlab 
(Mathworks, US) and then implemented as embedded software in a 
microprocessor based desktop unit (PulseTrace, Micro Medical Ltd, UK). In this 
unit, the signal is digitalised at 100 Flz and sampled with 8-bit resolution. Pulses 
are ensemble averaged and contour indices are derived from the averaged DVP. 
The algorithm used is described in the appendix section 10. The PulseTrace 
device was used to measure DVP in the studies described in chapters 6 and 8. 
2.3 Pulse wave velocity 
Pulse wave velocity (PWV) is a measure of arterial distensibility as 
explained in section 1.3. PWV can be measured using the Bramwell-Hill 
equation from the relative change of volume and pressure 
21 
. But a more practical 
approach is to measure transit time, the time the arterial wave takes to travel 
from one point to another point. The assessment of PWV then relies on the 
determination of the pulse transit time (TT) over an arterial segment of length 
PWV =L TT 
Determination of pulse transit time involves the measurement of the arterial 
pulse at 2 different sites. The pressure wave itself may 
be used (measured by 
tonometer) or, alternatively, another signal such as blood velocity 
(Doppler 
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probe) or wall movement (mechano-transducer) that bears a constant relationship 
with the pressure pulse. Measurements at the 2 different sites can be done 
simultaneously, or successively using the R-wave of an ECG as a time reference. 
Arterial length is estimated from surface markings between the 2 sites of 
measurement. 
The Sphygmocor (AtCor, Australia) device uses successive 
measurements of pressure waveforms and a simultaneous ECG. The pressure 
pulse is obtained with a high-fidelity applanation tonometer (Millar, Texas, US) 
as explained in section 2.1.1. For each measurement site, the delay from the R- 
wave of the ECG to the foot of the pressure pulse is detennined. Subtraction of 
the R-wave to pulse foot time at the proximal and distal sites provides the transit 
time. PWV is then calculated from the arterial length and transit time. 
2.4 Vasoactive drugs 
In this thesis, 4 different vasoactive drugs have been used to probe 
vascular function: glyceryl trinitrate (GTN), a non-endothelium dependent 
vasodilator, salbutarnol, an endothelium-dependent vasodilator and the 
vasoconstrictors angiotensin 11 and noradrenaline. 
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2.4.1 GTN 
GTN is routinely used to treat stable and unstable angina. As a powerful 
vasodilator, it vasodilates the coronary arteries, the resistance vessels (reducing 
peripheral vascular resistance and hence blood pressure) and causes veno- 
relaxation (hence reduces pre-load). In addition to these classical actions it is 
now recognised that GTN has an important effect on conduit arteries and 
muscular arteries proximal to resistance vessels. It is metabolised within smooth 
muscle cells to NO. NO stimulates cyclic guanosine monophosphate (cGMP) 
formation, which activates protein kinases, resulting in the dephosphorylation of 
myosin light chains of the smooth muscle hence producing muscle relaxation 120 
2.4.2 Salbutamol 
Salbutamol is a 02-agonist, primarily used in the treatment of asthma 
when administered by the inhaled route. Salbutamol acts on 02 receptors in 
bronchial smooth muscles to cause bronchodilation via an increase in cyclic 
adenosine monophosphate (cAMP). Salbutamol also causes vasodilation. This 
was thought to be mediated mainly through the activation Of P2 receptors on 
vascular smooth muscle (increasing cAMP as in the bronchial smooth muscle). 
However, P2 receptors are present on the vascular endothelium and it now 
acknowledged that much of the vasodilator action of salbutamol is due to 
activation of these receptors and subsequent release of endothelium derived 
NO 35 . Salbutamol, therefore, 
falls into the class of endothelium dependent 
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vasodilator drugs. These rely on the integrity of the endothelium and may be 
used to probe endothelium-dependent vascular function. 
2.4.3 Angiotensin 11 
Angiotensin 11 is a powerful circulating honnone regulated by the renin- 
angiotensin system. It has a direct vasoconstrictor action on vascular smooth 
muscle cells and increases noradrenaline release from sympathetic nerves. Both 
anglotensin 11 and noradrenaline act on the G-protein-coupled receptors of the 
smooth muscle cell to increase calcium ion concentration leading to muscle 
contraction 120 . Antagonism of angiotensin 11 by the use of an angiotensin 
receptor blocker (ARB) or by inhibition of its synthesis using an angiotensin 
converting enzyme inhibitor (ACEI, which inhibits conversion angiotensin I to 
angiotensin 11) is a common treatment for hypertension. In sections 5.5 and 7.6, 
anglotensin 11 will be used for its vasoconstricting properties. 
2.4.4 Noradrenaline 
Noradrenaline is released from sympathetic nerves and plays a major role 
in the regulation of vascular tone by the autonomic nervous system. 
Noradrenaline acts on G-protein-coupled receptors of the smooth muscle cell and 
increase calcium ion concentration leading to muscle contraction 
120 
. This drug 
has been used in chapter 3 to increase vascular tone. 
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2.5 Statistics 
Unless otherwise is stated, subject characteristics are presented as means 
± SD and results as means ± SE. Comparison of results between groups was 
performed by analysis of variance (ANOVA). The relationship between indices 
derived from the DVP and potential explanatory variables were explored using 
univariate and multivariate regression analysis. 
Repeatability was assessed as the mean within subject standard deviation 
(WSD) of measurements obtained on the same day and reproducibility as the 
WSD of measurements made on different days: 
WSD = Vmean _ 
var iance 
Repeatability and reproducibility were also expressed as the within 
coefficient of variation (WCV) 119: 
wcv = mean - var iance X100 
overall mean 
Correlation coefficients refer to Pearson correlation coefficients. 
Agreement between measurements was examined using with Bland- 
Altman Plots 18 in which the difference between two measurements is plotted 
against the mean of the two measurements.. The mean difference between 
measurements was used to quantitate the systemic error and the standard 
deviation of the differences the variation in agreement. 
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CHAPTER 3: Relationship between the 
peripheral and central pressure pulse 
46 
3.1 Background 
3.1.1 The augmentation index 
Since the introduction of cardiac catherisation in medical care, physicians 
have had the opportunity to observe characteristics of the aortic pressure 
wavefon-n. The aortic pressure waveform is the result of an interaction between 
the heart and the arterial system and, as described in section 1.1, is generally 
accepted to be determined by the summation of a direct wave and one or several 
reflected waves' 04 . During systole, the heart generates a 
direct wave, which 
propagates along the arterial tree. The direct wave is reflected at arterial 
bifurcations and at points where arterial diameter and distensibility change. 
Waves generated by these reflections can be seen as a single reflected wave, 
which travels backwards in the arterial tree and adds to the direct wave to fonn 
the observed aortic pulse 
104; 111 
Indices to characterise the pressure pulse can be derived from the contour 
of the pulse. The feature of the pulse contour, which has received the most 
interest, is the peak (or shoulder) that occurs in systole due to reflected waves. 
Murgo et al. 97 studied the contour of the pressure pulse in detail and were the 
first to define the augmentation index (Alx) as in figure 17. AN is a measure of 
the increase in BP caused by the return of the reflected wave during systole. AIx 
will depend on the characteristics of the reflected wave such as 
its timing (large 
artery stiffness) and its amplitude (related to peripheral vascular tone). 
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NIX 
=a X100 b 
figure 1T Definition of the Augmentation Index on the aortic pulse 
Aortic AIx has been widely studied and found to vary with age 
7; 62; 143; 153 
1 
BP 143; 149; 153 , gender 
153 body height 153 HR 148; 153 , aortic pulse wave velocity 
153 
and to be influenced by vasoactive drugs including caffeine 
81; 138 
. Aortic AN has 
been found to be higher in subjects with diabetes than in control subjects 136 and 
higher in subjects with hypercholesterolernia than in controls 145 . Vasodilator 
drugs such as GTN and salbutamol decrease Alx 144 . Alx also 
decreases during a 
hyperinsulhaemic euglycaemic clamp 141 . 
The contour of the pulse pressure wavefon-n differs according to the site 
of measurement 68; 1 09 due to the propagation and reflection of pressure waves 
throughout the vasculature"O. There is, however, little difference between the 
carotid pulse and the aortic pulse because the distance between the two arteries is 
relatively small. The carotid pulse is easily accessible and can be measured non- 
invasively with applanation tonometry. A carotid augmentation index (Alx-C) 
has been derived following the same definition (figure 17). AIx-C has been 
shown to be correlated with the aortic AIx 
28; 63 
, age 
5; 15; 60; 62; 76 
ý BP 
15; 76; 136 
1 
15-76 76 76 pWV76 
gender ,, body height , left ventricle ejection 
time , aortic and 
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tabacco consumption 15. The Alx-C has been found higher in hypertensive than in 
normotensive subjects 136 and has been reported higher in patients with end-stage 
renal disease compared with matched control subjeCtS77 . AIx-C decreases after 
treatment with nitrendipine or perindopril + indapamide, but not after 
3-15; 42; 136 
atenolol ,. In a recent study, AIx-C predicted cardiovascular survival in 
76 
patients with end-stage renal disease . 
Whilst the carotid pulse is easily accessible it can be difficult to obtain 
high quality waveforms due to the variability of underlying structures in the 
neck. By contrast, the radial pulse is easily accessible and the artery can be 
applanated against the radial bone without difficulty. The shape of the radial 
pulse is very different from the aortic pulse (figure 18). The propagation, timing 
and reflection of pressure waves in the vasculature"O cause the peripheral 
pressure pulse to differ from the central pressure pulse. Mechanical and elastic 
properties of the arterial tree distort the direct and reflected waves during their 
propagation and, especially in young subjects, the peripheral SBP is increased 
compared to central SBP 
30; 80; 108 
. 
figure 18: Radial and aortic pulses 
Radial pressure pulse (left panel) and aortic pressure pulse (right panel) 
decomposed in 
schematic manner into direct wave and reflected waves 
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In the radial wavefonn, the reflected wave usually causes a shoulder on 
the down-slope of the systolic part of the radial pressure pulse. A radial 
augmentation (AIx-R) can be defined using this shoulder (see figure 19). 
figure 19. - AIx-R definition 
The radial augmentation index has received much less attention than the 
aortic AN. It has, however, recently been used to assess endothelium function by 
looking at the vasodilator response to salbutamol47; 75 . The radial waveform is 
extensively use to estimate the central pressure pulse with the use of a transfer 
function. 
3.1.2 Notion of a transfer function 
34 6 56-57 Taylor' followed by Avolio et al. and Karamanoglu et al. , showed 
that the arterial tree could be successfully represented by a multi-branched model 
of elastic tubes. Applying the propagation theory of pressure waves in elastic 
tubes, a transfer function should exist relating the input pressure (aortic pressure) 
to the output pressure (peripheral pressure such as the radial pressure) of such a 
system. 
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A transfer function (TF) is a mathematical statement that describes the 
relationship between 2 variables in a system, S, andS2, which are functions of 
time (t) and can also be represented in the frequency domain (0. 




FT(S 1 (t)) 
S2(f) FFT(S 2 M) 
where FFT stands for Fast Fourier Transforrn. The Fourier transform is a 
mathematical way of expressing a temporal signal in the frequency domain. A 
temporal signal can be decomposed into a summation of several sinusoids of 
different frequency (Fourier's Theorem). Each sinusoid is characterised by its 
amplitude and phase. A signal may be represented in the frequency domain by a 
graph of the amplitude and phase of each sinusoid versus the frequency of the 
sinusoids. The transfer function between two signals S, and S2 may be 
represented by the ratio of their amplitude and their phase difference plotted 
versus frequency. 
58 Karamanoglu et al . 
first reported the existence of a generalised transfer 
function between radial and brachial pressure and aortic pressure wavefonns. 
They showed that TFs calculated for individual patients undergoing diagnostic 
cardiac catheterisation were similar and little influenced by administration of 
sublingual GTN. They averaged these "individual" transfer functions to produce 
a generalised transfer function that could be applied to calculate aortic pressure 
27 
from peripheral pressure in any patient. This was later confirmed by Chen et al . 
using a TF in the frequency domain on patients undergoing diagnostic cardiac 
catheterisation, by Sugimachi et al. 129 on patients with arrhythmias and by Fetics 
et al. 38 using a TF in the time domain. A generalised transfer function (GTF) has 
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been implemented in a commercially available device (Sphygmocor, AtCor, 
Sydney, Australia). 
3.1.3 Validation of the use of the transfer function 
Both radial and carotid waveforms can be used to synthesise the central 
pulse. However the most widely used approach is to perform radial artery 
tonometry, as it is simpler and better tolerated by the patient. Carotid tonometry, 
on the other hand, requires a high degree of technical expertise 
28; 107 
The validation of the commercially available radial to aorta TF has been 
assessed by several investigators. However, most assessments of the accuracy of 
the TF in synthesising the aortic pressure pulse from the radial pulse have 
focused on the estimation of aortic SBP and not on features of the contour of the 
aortic waveform such as the AN. Pauca et al. 115 recruited 62 patients undergoing 
cardiac surgery and simultaneously recorded invasive radial and aortic pressure 
waveforms before and during GTN infusion. The difference in aortic SBP 
between the measured and the synthesised aortic pulse was 0.1 ± 4.3 mmHg 
(mean ± SD). Segers et al. 125 compared invasive aortic and radial pressure 
wavefonns in 45 patients before cardiac procedures and after GTN infusion 
(n=40). AN from the reconstructed aortic pulse underestimated measured aortic 
AN by 4± 16% at baseline and by 2± 15% after GTN (errors in AIx are given in 
percentage units and not as a percentage of the measured value). Sbderstrbm et 
al. 127 measured the true aortic pressure waveforms on 12 patients with angina 
pectoris and compared them to the estimated aortic pressure from the radial pulse 
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measured by tonometry. The patients were studied at rest, following midazolam, 
sublingual GTN and during Valsava manoeuvres. They concluded that aortic 
SBP was underestimated by 6 to 8 mmHg. The difference in measured aortic AN 
and estimated aortic AN was 6±9.5% (estimated from their Bland-Altman 
grap 127 . Results from studies in which the accuracy of the TF for predicting 
central SBP and aortic AN has been examined and shown in table 1. 
Investigator Method Error in SBP Error in AN § 
non-invasive radial 
Chen et al . 
27 
0±3.7 mmHg -7 ±9% invasive aortic pulse 
non-invasive radial -54 ± 232 %% Fetics et al. 
38 t 0.4 ± 2.9 mmHg 
invasive aortic pulse (% error in AN) 
invasive radial 
Karamanoglu et al . 
58 2.4 ± 1.0 mmHg 
invasive aortic pulse 
invasive radial 
Pauca et al. ' 
15 0.1 ± 4.3 mmHg 
invasive aortic pulse - 
invasive radial 
Segers et al. 
125 3± 16% 
invasive aortic pulse 
non-invasive radial 
S6derstr6m et al. 
127 6 to 8 mmHg 6±9.5 % 
invasive aortic pulse 
table I. - Validation studies of the radial-aortic transferfunction 
* denotes authors who use the same data to generate a TF and validate it 
f denotes authors who have used their own TF and not the commercially available one 
§ errors in AIx are expressed in % units not in % of the measured value unless stated otherwise 
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An important difference between these studies was the method used to 
measure the radial pressure pulse. Pauca et al. ' 15 and Segers et al. 124 measured it 
invasively and validated the use of the commercially available TF to estimate 
central BP. S6derstr6m et al. 
127 
, Chen et al. 
27 
and Fetics et al. 
38 
used the 
tonometry technique to assess the radial pulse. Although tonometry has been 
shown to provide similar waveforms to those obtained by direct intra-arterial 
pressure monitoring 61 , non-invasive recording might add some additional error in 
the estimation of the aortic pulse. This could also explain why SMerstr6m et al. 
observed an underestimation of the SBP. Calculated values for SBP fall broadly 
within the range specified for the AAMI and BHS requirements 106 at least for 
directly recorded radial waveforms. The error between the measured and 
estimated AN is substantial (--5% units) compared to average AN values (about 
20%) and to the changes expected after biological effects. The second important 
point relates to the spread of this error around the mean, which is expressed by 
the standard deviation (SD). The SD of the error ranges from 9 to 16%, which is 
considerable compared to biological effects. For example, five years of vascular 
ageing is associated with an increase in Alx of 6.3 %60 . The difference between 
control and diabetic subjects is 6.3 %150 and between control and 
145 hypercholesterolemic patients 9.2% . 
Compared to these values, an error of 5% 
between measured and estimated AN is considerable. 
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3.1.4 Reproducibility of the estimated central waveform 
The reproducibility of measurements obtained with the Sphygmocor has 
been studied by several authors 
126; 147 (table 2). Wilkinson et al. 
147 looked at the 
reproducibility of the aortic AN estimated by transformation from the radial 
artery. They found a within-observer difference of 0.5% ± 5.4% (mean ± SD) 
and a between observer difference of 0.2% ± 3.8%. Siebenhofer et al. 126 studied 
the inter-operator variability of aortic SBP and aortic AN obtained from the 
radial pulse. Intra-operator difference was 0.1 ± 1.7 mmHg for aortic SBP and 
0.4 ± 6.4% for AN. 
Investigators Index 
Benetos et al. 
15 Carotid AIx reproducibility: 8.1 ± 4.4 % 
within observer variability: 0.5 ± 5.4 % 
Wilkinson et al. 
147 AIXTFR 
between observer variability: 0.2 ± 3.8 % 
difference between repeated measures: 
Yasmin et al. 
153 AIXTFR 
0.18 ± 4.7 % 
Siebenhofer 126 AIXTFR mean difference (±SD): 0.4 ± 6.4% 
Westerbacka et al. 
141 AIXTFR coefficient of variation: 5± 1% 
table 2: Results of reproducibility studies on AIx 
AIxTFR .- aortic 
AR estimatedfrom the radial pulse with a transferfunction 
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From these data the fact that the SD of the difference between measured 
and estimated aortic AN is up to 16% (see section 3.1.3) and the SD of the 
variability up to 6.4 % is worrying. An error of 10% in the detennination of AN 
represents an error of 8 years of vascular ageing, or a change of 25 bpm in HR. 
However the difference between measured and estimated aortic SBP is of a 
smaller scale (up to 8 mmHg). 
The transfer function has been established and validated with invasive 
measurements of aortic pressure waveforms, which have been obtained during 
catherisation. For ethical reasons, subjects undergoing aortic catherisation are 
usually unhealthy and generally of an older age. The generalised TF may thus be 
less suitable for a younger healthy population. 
The accuracy of the TF for estimating aortic SBP but inaccuracy in 
estimating AN may be explained by the variability of individual TFs at high 
frequencieS27; 38; 57 . Figure 20 shows that 
individual TFs are similar at frequencies 
up to 4Hz but from 4Hz to lOHz the 95% confidence interval (representing the 














fi! zure 20: Radial-aortic transferfunction 
Transferfunction with 95% confidence intervals (representing the variation between individuals 
TTs). Open circles with errors barsfrom Karamanoglu et al. 
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, solid line with shaded areafrom 
Chen et al. 





figure 21: Importance of the various harmonics 
The original pulse (blue), the pulse constructedftom thefirst 3 harmonics (red) and the pulse 
constructedftom thefirst 10 harmonics (green). 
In figure 21, the relative influence of high frequency hannonics is shown. 
With 3 hannonics (equivalent of 41-1z for a sub ect with HR=60bpm), systolic j 
and diastolic pressure are properly determined. However AN depends upon 
higher frequency components of the waveform. The discrepancy between the 
individual TFs above 4 Hz might explain why the generalised transfer function 
(GTF) is relatively accurate in estimating central SBP whereas estimation of AN 
is less acceptable. In figure 22, the influence of the high frequency variability of 
the TF on the synthesised aortic pulse is shown. The TF used is as described by 
Chen et al. 27 with the upper and lower 95% confidence limits of the individual 























Synthesized aortic pulse 
figure 22: Influence of the TF on the synthesised aortic pulse 
The radial to aortic transferfunction described by Chen at al. 27 (middle panel) applied to a 
typical radial waveform (left panel) using the upper and lower 95% confidence limitsfor the 
coefficients (dotted lines). The resulting synthesised aortic waveforms (right panel) exhibit little 
variation in systolic pressure but marked variation in the aortic AIx. 
3.2 Aims 
The transfer function (TF) has been established and tested mainly with 
regard to estimation of central SBP in older subjects with coronary artery 
diseases. Reservations regarding the TF approach to derived AN are discussed 
above. The aim of this study was to re-evaluate the accuracy of the TF approach 
especially in younger healthy subjects. For ethical reasons access to invasive 
aortic pressure pulse is not possible in healthy subjects, so the carotid pulse 
which bears strong similarities to the aortic pulse 
28; 63 
was used. 
The aims of the study were to: 
compare aortic SBP derived by application of a 
TF to the carotid (aortic 
SBPTFc) and radial pulse (aortic SBPTFR) 
2/ compare AN derived by application of a 





3/ determine the relationship between the AN derived directly from radial pulse 
(AIx-R) and the aortic AN derived after application of the TF to the radial 
pulse (AIXTFR). 
Healthy subjects and older subjects with hypertension and coronary artery 
disease were studied in order to obtain a high range of values of AIx. In a sub- 
group of healthy subjects, vasoactive drugs were administered to determine 
whether changes in aortic AN tracked those in the radial AN (AIx-R). 
3.3 Methods 
Studies were performed with the approval of St Thomas' Hospital 
Research Ethics Committee and with the written informed consent of the 
subjects. Three groups of subjects were studied: healthy volunteers (n=30, age: 
37±8 years, BP: 119±11/69±8 mmHg, mean ± SD), subjects with uncomplicated 
essential hypertension (n=30, age: 51±13 years, BP: 142±22/89±14 mmHg) and 
patients with coronary artery disease (n=23, age: 57±8 years, BP: 131±19/79±9 
mmHg). Measurements were performed with subjects supine in a quiet 
temperature controlled environment after at least 15 min at rest. Radial and 
carotid arterial pressure wavefonns were obtained by applanation tonometry 
(Millar Instruments, Texas) as describe in section 2.1.1 with Sphygmocor 
software version 6.3 (AtCor, Australia). Three successive recordings were 
obtained from each artery and measurements were repeated if the waveform(s) 
did not pass the automatic quality controls specified by the Sphygmocor 
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software. Brachial artery BP was measured in triplicate with an oscillometric 
device (Omron 705CP, Omron, Japan) and the mean of 3 readings used to 
calibrate the radial pressure pulse. The carotid pressure pulse was calibrated 
using the diastolic and mean arterial pressure obtained from the calibrated radial 
pulse. The aortic pulse was synthesised from the radial pulse and from the carotid 
pulse using the transfer functions supplied by Sphygmocor. 
Effects of vasoactive drugs were assessed in a subset of 12 of the healthy 
volunteers. A similar protocol was used to obtain carotid and radial pressure 
pulse recordings at baseline and during the last 10 min of a 15 min intravenous 
infusion of noradrenaline (50 ng. kg-l. min-1, n=8) or GTN(100 ptg. min-1, n=4). 
Statistics 
Agreement between estimates of the same measurement was assessed by 
Bland-Altman plots. The mean difference between measurements was used to 
quantitate systematic error and the standard deviation of the differences the 
variation in agreement' 8. Pearson correlation coefficients are also presented with 
the recognition that these are of limited value in the comparison of closely 
related measurements' 8. Different measurements (aortic and radial AN) were 
compared by regression analysis. A Bland-Altman plot was used to compare 
aortic Alx with aortic AIx predicted from Alx-R (using the coefficients of the 
regression equation of radial vs. aortic AN). P<0.05 was considered significant. 
All tests were 2-tailed. 
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3.4 Results 
3.4.1 Central systolic blood pressure 
Values of central SBP computed from the radial pulse using the radial to 
aortic TF were in close agreement with those computed from the carotid pulse 
using the carotid to aortic TF (figure 23). Correlation coefficients were 0.87,0.99 
and 0.99 in control, hypertensive and CAD groups respectively. Mean ± SD 
differences between values obtained from the transformed radial and carotid 
wavefonns in the respective groups were 0.03±5.3, -2.0±4.7 and -1.0±3.4 
mmHg. The overall correlation coefficient for all groups was 0.98 and the mean 
difference -0.9±4.6 mmHg. Two standard deviations (2SD, the Bland-Altman 
statistic giving the confidence limits within which, assuming a normal 
distribution, 95% of readings will be in agreement) of the difference between the 
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figure 23: Central systolic bloodpressure 
Comparison of aortic systolic bloodpressure (SBP) estimated by applying transferfunctions to 
radial (SBPTFR) and carotidpulse waveforms (SBPTFC) in control subjects (s), hypertensive 
subjects (x) and subjects with coronary artery disease (o): a) scatter plot; b) Bland-A ltman plot 
of difference in SBP (ASBP= SBPTFR - SBPTFC) versus mean SBP. The solid line represents the 
mean difference and the dashed lines are 2 standard deviationsfrom the mean. 
3.4.2 Aortic Alx 
Mean values of aortic AN estimated from the transformed radial 
wavefon-n (AIXTFR) were 8.3±8.7,27.9±10.6 and 29.5±11.8 % in control, 
hypertensive and CAD patients respectively. Agreement between 
AIXTFR and 
AIXTFCwas relatively poor with correlation coefficients 0.47,0.83 and 0.84 and 
mean differences -3.8±12.4, -8.8±6.0 and -5.8±7.1 mmHg 
for the control, 
hypertensive and CAD groups respectively. The overall correlation coefficient 
for all groups was 0.84 and the mean difference -6.2±9.2%. 
The SD of the 
63 
difference (2SD = 18.4 %) was substantial in comparison with the difference of 
approximately 20% seen between mean values of AN in the control and 
hypertensive/CAD patients. Similar results were obtained when AIXTFR was 
compared with carotid Aix, a validated estimation of the aortic Aix 28 (overall 
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figure 24: Aortic augmentation index 
Comparison of aortic augmentation index estimated by applying transferfunctions to radial 
(ARTFR) and carotidpulse waveforms (AIxTFC9 in control subjects (s), hypertensive subjects (x) 
and subjects with coronary artery disease (q): a) scatter plot; b) Bland-A ltman plot of 
difference 
in AR (AAlx= AIxTFR - AIxTFCq versus mean AIx. The solid 
line represents the mean difference 
and the dashed lines are 2 standard deviationsfrom the mean. 
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3.4.3 Comparison of aortic with radial AN 
There was a close approximately linear correlation (R>0.92 within each 
group and R=0.96 for all groups, figure 25) between AIXTFRobtained by applying 
a TF to the radial wavefonn and AIx-R obtained without use of a TF. For 
comparison with previous data, a Bland-Altman plot was constructed for the 
difference between aortic AN and AN estimated from the regression line relating 
aortic to radial AIx. 2SD of the difference was 5.4%, less than that seen for the 
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figure 25: Aortic AR and radial AIx 
Comparison of aortic augmentation index (AIx) estimated by applying a transferfunction to the 
radial arterial waveform (AIxTFR) and radial AR obtained without a transferfunction in control 
subjects (o), hypertensive subjects (x) and subjects with coronary artery disease 
(b): a) scatter 
plot; b) Bland-A ltman plotfor the difference (AAR) between aortic AR predictedfrom the radial 
AR (using the coefficients of the regression equation of radial AR versus AIxTFR) and radial 
AR 
versus mean AIx. The solid line represents the mean difference and the 
dashed lines are 2 
standard deviationsfrom the mean. 
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Changes in aortic AN produced by GTN and noradrenaline correlated with those 
in radial AN (R=0.93, P<0.0001, figure 26). 
. o-.. 
0 AAlXTFR ( /0) 
figure 26: Effects of vasoactive drugs 
Change in aortic AIx(AAIxTFR estimated by applying a transferfunction to the radial artery) and 
change in radial AIx (A4Ix-R, obtained without using a transferfunction) during intravenous 
infusion ofglyceryl trinitrate (open symbols) and noradrenaline (closed symbols). 
3.5 Discussion 
The transfer function (TF) used to estimate the central pressure pulse 
from the radial pulse has been calculated in patients in whom direct 
measurements of aortic pressure can ethically be obtained. So the TF has been 
established in patients undergoing cardiac catheterisation, such as patients 
66 
undergoing diagnostic angiography or post heart transplant27; 
38; 58 
. The validation 
studies have focussed mainly on the accuracy of determining SBP and this falls 
05; 106 within the range of the BHS requirements' . However, in studies in which the 
accuracy of the TF for detennining aortic AN has been assessed, the discrepancy 
between values of AN obtained using a TF and measured values are quite high 
compared with patho-physiological changeS27; 
38. 
In the present study, the agreement between measures of SBP and of 
aortic AN obtained from transformed radial and carotid pressure waveforms 
have been compared. The agreement between estimates of central SBP were 
within acceptable limits in all groups of subjects with the mean difference less 
than 2±5.3 mmHg (mean ± SID). This is consistent with validation studies in 
which aortic pressure estimated from the radial pulse has been compared with 
27; 115 direct intra-aortic recordings 
In contrast to central systolic pressure, estimates of aortic Alx derived 
from the radial (AIXTFR) and carotid (AIXTFC)wavefon-ns showed relatively poor 
agreement, especially in young healthy subjects. In these subjects there was no 
significant correlation between values of 
AIXTFR and AIXTFC. Two SDs of the 
difference was 18.4 % units (see Bland-Altman plot, figure 25). This difference 
is large in comparison with patho-physiological changes. A change of 
approximately 14%, for example, is seen in association with 10 years of ageing 
60 
. 
In the above data, the difference between young healthy subjects and older 
CAD 
patients was about 20%. This discrepancy between values of 
AIx derived by 
applying transfer functions to the carotid and radial arteries suggests 
that one, or 
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other, or both of the transfer functions are of limited accuracy in predicting aortic 
AN especially in healthy subjects. 
The validity of carotid-aortic TF has not been studied as much as the 
radial-aortic TF. However because the pressure waveform and the change in the 
wall properties with ageing are similar in the carotid artery and in the ascending 
aorta 63 , several studies have used the carotid pulse as a direct estimation of the 
aortic pulse. The carotid artery is close to the aorta, and the assumptions that 
arterial properties (path length, impedance mismatched) determining the TF may 
be more justified. Indeed the aortic AN can be estimated from the carotid 
without use of a TF 28 and we found similar discrepancy between AIXTFR and 
AIx-C to that between AIXTFRand AIXTFC. The error could have arisen from the 
carotid tonometry measurements, as it can be quite difficult to obtain a consistent 
beat to beat carotid pressure pulse in some subjects'O'. However, great care was 
been taken in this study to obtain the best waveforms possible and traces of poor 
quality were discarded. So the majority of the error is most likely to reside in the 
radial to aortic TF. The transfer function used is a "generalised transfer function" 
(GTF) calculated from TFs from individual subjects. It assumes that the 
properties of the arterial tree between the radial artery and the aortic arch are the 
same in everybody under all conditions. This is obviously quite a generous 
assumption as the body size, age, presence or absence of arteriosclerosis and 
atherosclerosis and other parameters influence the arterial pathway. This 
assumption holds for the frequency components determining central SBP but not 
for those detennining AN. The discordance in the accuracy of the TF with 
central SBP and aortic AN is consistent with the characteristics of the transfer 
function. SBP is determined by the coefficients for the lower frequencies and 
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these coefficients show much less spread than those for the higher frequencies, 
which influence AN (see figure 21 and figure 22). When the GTF and the 95% 
confidence intervals TF are applied to the same radial pulse, a difference up to 
15% can be observed for the AN, whereas the values of SBP are equivalent (see 
figure 22). 
The GTF is a good tool to determine central SBP from the radial artery. It 
may not, however, be necessary to use it to assess central pressure wave 
reflection. In the present study we observed a close correlation (R > 0.92 in all 
groups) between the AIXTFR derived by application of a GTF to the radial 
waveform. and the AIx-R calculated directly without use of a GTF. Furthermore 
when changes in AN were induced by vasoactive drugs there was a highly 
significant correlation between changes in AIXTFR and AIx-R. That a close 
relation between aortic and radial AN should exist is not unexpected. A transfer 
function does not add any infonnation, so everything contained within the 
transformed waveform should be possible to infer directly from the radial 
wavefonn. What is surprising is the linear relationship between 
AIXTFRand radial 
AN (Alx-R). This means that AIx-R may provide an equally good measure of 
central pressure wave reflection and has the advantage that it is not dependent on 
a relatively arbitrary manipulation of the wavefon-n derived from observations 
made in a selected groups of subjects. 
In conclusion, our findings suggest that transfonning the radial pulse to 
the central pulse may be not necessary and that the peripheral pulse could 
be 
used directly to study the wave reflections. 
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CHAPTER 4: Relationship between the 
pressure pulse and the volume pulse 
70 
4.1 Background 
The digital volume pulse (DVP) can be obtained by measuring infra-red 
light transmission through the finger by photoplethysmograph Y36; 
78; 94 
as 
described in section 2.2. Miffler and WeiS96 in 1911 were the first to mention that 
the DVP and the pressure pulse bear some similarities. In 1939, Hertzman when 
studying the DVP, noted that "the volume Pulse is here (in the digit) 
indistinguishable in form from the peripheral arterial pulse'548 . The description 
of changes in the DVP occurring after GTN by Hertzman 48 and Morikawa 94 
mimic the changes described in the peripheral pressure pulse 
59; 98 
. These observed 
similarities make it attractive to explain the characteristics of the DVP with the 
same theory applied to the pressure pulse contour. 
The pressure wavefonn has been subject to extensive analysis and it is 
now well accepted the pressure waveform is fonned by a direct wave and several 
reflected waves arising mainly from the lower body as described in section 1.1. 
The amplitude and the velocity of the reflected waves largely determine the 
contour of the pressure pulse. The DVP is formed by the pulsatile component of 
infra-red light transmitted through the finger pulp. Infra-red light is mainly 
absorbed by oxyhemoglobin in the blood, so the DVP follows changes in the 
blood volume in the fmger pulp. If it is assumed that the blood volume in 
capillaries and veins remains approximately constant during the cardiac cycle, 
the DVP would be caused by changes in blood volume in the digital artery and 
possibly in arterio-veinous shunts. Variations of the digital intra-arterial pressure 
during the cardiac cycle distend the arterial wall and so increase blood volume in 
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the arterial segment and downstream vessels and thus generate the DVP. Because 
of the elasticity and the viscosity of the arterial wall, wall displacement is not 
linearly related to the arterial pressure pulse 104 but a relationship should exist 
between the DVP and the pressure pulse. 
As described in the previous chapter, the central pressure pulse can be 
estimated from the peripheral pressure waveform with the help of a generalised 
transfer function (GTF). The use of the GTF is based on the assumption that the 
difference between various subjects in the physical properties of the transmission 
path between the radial (or carotid) and aortic artery on different subjects is 
negligible. If the physical properties of the arterial tree in the finger that 
determine the DVP are reasonably similar, a GTF should exist between the DVP 
and the digital pressure pulse or radial pressure pulse. 
4.2 Aim 
The aim of this study was to establish whether a simple TF can be used to 
relate the DVP to the radial and digital artery pressure pulses in healthy subjects 
and in patients with essential hypertension. The effect of administration of the 
vasodilator GTN was examined to verify if TFs between the DVP and pressure 
pulses depend on local vasodilation. 
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4.3 Methods 
4.3.1 Subj ects 
Healthy normotensive (n=40,118±11/67±9 nu-nHg, mean ± SD) and 
hypertensive subjects (n=20,152±14/92±12 mmHg) aged 24 to 80 years 
(including 10 women) were recruited from the local community in south-east 
London. None of the hypertensive subjects had clinical evidence of 
cardiovascular disease other than hypertension. Twelve were receiving anti- 
hypertensive therapy at the time of the study (diuretics: 7/12; beta-adrenoreceptor 
antagonists: 5/12; alpha-adrenoreceptor antagonists: 1/12; ACE inhibitors: 3/12; 
anglotensin 11 receptor antagonists: 2/12; calcium channel blockers: 4/12). 
The study was approved by St Thomas' Hospital Research Ethics 
Committee and all subjects gave written infon-ned consent. 
4.3.2 Pressure and volume pulse recordings 
The DVP was determined using a finger probe (as described in section 
2.2.2) applied to the index finger of the right hand. A pen-like tonometer (Millar 
SPT 301, Millar Instruments, USA) was used to record radial artery pressure and 
was applied over the radial artery of the left arm (see section 2.1.1). Digital 
artery pressure was measured non-invasively on the middle finger of the right 
hand using the Finapres device (Finapres 2300, Ohmeda, USA) as 
described in 
73 
section 2.1.2. Signals from all transducers were recorded via a 12-bit analogue to 
digital converter (sampling frequency 100 Hz) on a PC. Further digital signal 
processing was perfon-ned off-line with Matlab TM (MathWorks, USA). Brachial 
artery pressure (left arm) was measured using an automated oscillometric method 
(Dinamap, Critikon, UK). 
4.3.3 Protocol 
Subjects rested supine in a temperature-controlled laboratory (26±1'C) 
for 30 min to allow HR and BP to stabilise. Simultaneous pressure and DVP 
waveforms were recorded for 30 seconds at 5 minutes intervals for 15 min. In a 
subset of 20 of the normotensive subjects GTN (500 ýtg) was then administered 
sublingually and further simultaneous volume and pressure recordings were 
obtained 3 min after GTN when effects of GTN were maximal. GTN was used to 
induce a change in the shape of the pressure and DVP waveforms in order to 
examine whether the relationship between pressure and DVP pulses remains 
constant despite a vasodilator stimulus. 
4.3.4 Data analysis 
Since the purpose of the study was to compare the shape of the 
waveforms, the amplitude of the DVP was non-nalised to be equal to that of the 
pressure pulse. Pulses from each cardiac cycle were identified (see algorithm in 
appendix 10.4) and normalised in time and amplitude in order to obtain an 
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average pulse. Normalisation was performed using a cubic interpolation to a 
fixed number of samples. After normalisation, an average pulse was constructed 
by taking the mean of the signal at each time points. Brachial BP was used to 
calibrate pressure signals from the tonometer and the Finapres. 
Transfer Function (TF): 
For each measurement a transfer function (TF) was determined in the 
frequency domain from pressure and DVP pulses as shown below. 
TF(PradNdig) = FFT(Prad)/FFT(Vdig) (1) 
TF(Pdig/ Vdig) = FFT(Pdig)/FFT(Vdig) (2) 
Prad = radial artery pressure 
Vdig= digital volume 
Pdig = digital artery pressure 
FFT = Fourier Transform 
A TF for each volunteer was computed at baseline (using 3 consecutive 
measurements at 5 minute intervals) and 3 minutes after GTN (when changes due 
to GTN were maximal). Each measurement was determined using a minimum of 
6 consecutive stable cycles obtained simultaneously on all three transducers. 
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Since harmonics greater than 10 do not contribute significantly , only the 
first 
10 harmonics of each waveform were used for the analysis. 
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General Transfer Function (GTF): 
A general transfer function for control wavefonns (GTF, ) was derived by 
averaging all TFs at baseline. A general transfer function after GTN (GTFGTN) 
was derived from TFs obtained 3 min after GTN. GTF, and GTFGTNwere used to 
calculate a mean general transfer function (MGTF) for all subjects (weighted 
average). The MGTF was used to predict pressure waveforms from the DVP 
waveforms. 
Measure of agreement: 
The agreement between predicted and measured waveforms was 
quantified by the root mean square (RMS) difference between the two signals. 
Statistical analysis: 
Results are presented as means ± SD. Analysis of variance (for repeated 
measures where appropriate) was used to compare RMS errors between the 
groups and waveforms. P<0.05 was taken as significant. 
4.4 Results 
Typical DVP and pressure waveforins are shown in figure 27. Radial and 
digital pressure waveforms were in close agreement in all subjects. The mean 
RMS error for the difference between radial and digital pressure wavefonns was 
4.4±1.4 mmHg (mean for all subjects ± SD). The DVP signal differed 
from the 
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pressure signals (figure 10) with the main difference being in the height of the 





































figure 27: DVP andpressure waveforms 
Examples of the digital volume waveforms (DVP), digital pressure waveforms (Pdid and radial 
pressure waveforms (P, d) for normotensive and hypertensive subjects and in normotensive 





Following administration of GTN to a subset of the normotensive 
subjects, SBP fell by 1.2±6.0 mmHg (P=NS) and DBP by 5.2±3.8 mmHg 
(P<0.001). Figure 28 shows the GTF for normotensive subjects before and after 
GTN and the GTF for hypertensive subjects. As they are similar, we calculated 
the mean general transfer function (MGTF) from GTFs derived from all subject 
groups (control nonnotensive, GTN normotensive and hypertensive subjects). 
It has to be noted that the phase of the TFs are negative for frequencies 
b) Pad / DVP 
above 4Hz. This does not represent a real time shift of the highest frequencies, 
but this is due to the process used to calculate the TF. As explained in section 
10.45 TF were determined from averaged DVP and pressure pulses, which were 
arbitrarily aligned in time (with respect to the foot of the pulse). This is 
responsible for producing negative phase values. 






















figure 28: GTFfor normotensive and hypertensive subjects 
Generalised transferfunctions (GTF) relating a) digital artery pressure 
(Pdidto the digital 
volume pulse (D VP) and b) radial artery pressure 
(Pd, ) to the D VP in normotensive and 








Pressure waveforms reconstructed from the DVP waveforrn with the 
MGTF are shown in figure 29. Transfornied DVP waveforms were in close 
agreement with measured pressure waveforms in each artery. The RMS error 
between the transformed DVP and pressure waveforms was similar to the RMS 
error between the two pressure waveforms. For all subjects, the mean RMS error 
between transformed DVP and tonometer radial pressure signals was 4.4 ± 2.0 
mmHg, and that between transformed DVP and Finapres digital artery pressure 
signals was 4.3 ± 1.9 mmHg. These errors did not differ significantly from the 
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figure 29: Pressure waveforms predictedfrom the digital volume pulse 
Averaged waveformsfor a) the digital artery (Pdid and b) the radial artery (P, d) 
in 
normotensive, hypertensive and normotensive subjects after glyceryl trinitrate 
(GTN). The solid 
lines shows measured waveforms and the dotted lines waveforms predicted 
by applying a single 
generalised transferfunction to the digital volume pulse(D 
VP). 
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4.5 Discussion 
In the present study we obtained close agreement between waveforms 
derived from the tonometer and Finapres (RMS error = 4.4 ± 1.4 mmHg). Both 
instruments have been shown to provide waveforms, which closely approximate 
intra-arterial pressure 61 ý62 . The small discrepancy between the waveforrns 
obtained from the Finapres and the tonometer reflects the limits of accuracy of 
these devices. Agreement between recorded pressure waveforms and waveforrns 
reconstructed from the DVP using a single generalised transfer function (GTF) 
was similar to that between the tonometer and Finapres. Thus a simple TF can be 
used to transform the DVP into the pressure pulse. The accuracy of this TF is 
similar to the one obtained by Karamanoglu 
55; 58 
and Chen 
27 for the relation 
between peripheral and central waveforms. They found that TFs from peripheral 
pressure pulses to central pressure pulses are similar in different individuals and 
independent of effects of vasoactive drugs 
27; 58 
. The TF 
from the DVP to 
peripheral pressure also remains constant, irrespective of the effects of 
hypertension or effects of vasodilation produced by GTN. 
The relationship between DVP and pressure in the digital artery is 
determined by the impedance characteristics of vessels in the finger distal to the 
digital arteries. The constancy of the relationship between DVP and pressure in 
the presence of large changes caused by GTN suggests that effects of 
GTN on 
peripheral impedance characteristics of the finger are minor 
in comparison with 
changes in arteries in the lower body, which alter wave reflection. 
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In the present study, a frequency based TF approach was used. The use of 
a parametric TF has been shown to improve the stability and estimation in the 
prediction of central BP from peripheral pulse. A parametric approach to the 
relationship between the DVP and the pressure pulse might improve the 
goodness of fit but is very unlikely to alter the conclusion that the DVP and the 
pressure pulse contain the same information. 
As the same information is contained in the pressure pulse and in the 
DVR, the physical properties altering the pressure pulse are very likely to 
produce the same effect on the DVP. The wave propagation and reflection theory 
should hence apply to the DVP. The following chapters will deal with the 
measurement of wave reflection and velocity from contour analysis of the DVP. 
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CHAPTER 5: Influence of vasoactive drugs 
on the DVP 
82 
5.1 Background 
There is a wealth of data conceming the effect of vasoactive drugs, 
particularly organic nitrate, on the DVP 
14; 23; 44; 65; 78; 89; 123; 128; 139; 140; 151. Despite this, 
the physical properties of the arterial tree detennining the change in the DVP 
induced by drugs is poorly understood. Effects of nitrates on the DVP, have been 
128 various y attributed to local effects, changes in pre-load , changes in cardiac 
output 
128 
and changes in aiterial tone 
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ln the previous chapter, it has been shown that the DVP and the pressure 
pulse are related by a generalised transfer function (GTF) independent of 
individual variation and interventions. So, the DVP contains the same 
information as the pressure pulse and it is thus most likely that the DVP is 
influenced like the pressure pulse by pressure wave transmission and reflection. 
Like the pressure pulse, the first peak of the DVP will then correspond to a direct 
wave travelling from the heart to the finger and the second peak to a wave 
reflected from the lower body as shown in figure 30. The amplitude of the 
reflected wave (the 2d peak) will depend on the amount of reflection. The time 
delay between the direct wave (I" peak) and the reflected wave (2 nd peak) will be 
determined by the speed of wave propagation (PWV). In the pressure pulse, 
effects of nitrates are attributed to a reduction in pressure wave reflection. 
Nitrates will therefore be expected to influence the DVP by reducing the 
height 
of the second peak. This is indeed the case with many observers reporting an 
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increase in "dicrotism of the DVP": a reduction in the height of the second peak 
and increase in the intervening "notch" between the I" and 2 nd peak. 
direct wave led 
figure 30: Summation of the direct and reflected wave. 
5.2 Definition of RI, a reflection index 
The "dicrotic index" described by Morikawa might better be tenned a 
reflection index. In this chapter, the use of a reflection index (RI) defined as 
RI =b? 100 where b is the amplitude of the second wave and a the total a 
amplitude of the pulse, is explored. This definition is not new as it has previously 
been used to measure effects of nitrate poisoning and other vasoactive drugs 
78; 94; 95; 151 
RI = b/a *100 
figure 3 1: R-1 definition. 84 
5.3 Aims 
The aim of this chapter was to examined the influence of vasoactive 
drugs on the DVP. Local intra-arterial infusions were studied to verify that the 
characteristics of DVP contour are not influenced by local effects. The influence 
of the vasodilator GTN and the vasoconstrictor angiotensin 11 on RI was then 
Stu le . To determine whether effects of these drugs are mediated 
predominantly by changes in large or small arteries, aortic pulse wave velocity 
and BP will be measured as well. 
5.4 Study 1: Local effects 
5.4.1 Methods 
To check if RI could be affected by local changes in arterial 
characteristics, GTN was infused in the right brachial artery using a 27-gauge 
steel needle (Coopers Needleworks, Binningham, LJK). After baseline 
measurements, during infusion of saline alone, 4 cumulative doses of GTN (0.1, 
0.3ý 1.0 and 3.0 ptg/min, David Bull Laboratories, Australia) were infused each 
for 5mm. Forearm blood flow was measured in both arms by venous occlusion 
strain gauge plethysmography 
142 
. The mean of 
5 venous occlusions during the 
last 2 min of each infusion period were used for analysis. 
The DVP was 
85 
measured simultaneously from the index finger of the left and from the right 





figure 32: Protocol to examine effects of local vasodilation on RI. 
RI was calculated from the DVP with the algorithm explained in section 
10.2.2. Briefly, when the DVP exhibits a defined peak, RI was defined as the 
height of the local maximum of the DVP downslope (figure 33, left panel) 
divided by the amplitude of the DVP. With ageing and vascular diseases, as 
observed by several authorS34; 
36; 71 
, the second peak may disappear and only an 
inflection point on the downslope of the DVP is observable. In that case, RI is 
defined as the height of the inflection point (local maximum of the first 






figure 33: Definition of the 2 "d peaklinflection point 
5.4.2 Results 
Brachial infusion of GTN produced a small but significant fall in RI in 
both fingers. RI decreased from 60 ± 5.5 % to 53 ± 5.8 % (P<0.05) in the 
infused arm and from 63 ± 5.1% to 49 ± 6.3% (P<0.05) in the non-infused arm. 
The ratio of RI in the infused to that in the non-infused arm remained constant 
(figure 34). Forearm blood flow increased significantly in the infused ann from 
9.8 ± 2.0 to 22.4 ± 2.4 ml/min per 100ml. There was no significant change in 
blood flow in the non-infused foreann. Thus the ratio of blood flow in the 
infused/non-infused foreann increased significantly (see figure 34, P<0.001 for 
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figure 34: Influence of GTN on RI andforearm bloodflow 
Ratio of leftforearm bloodflow and rightforearm bloodflow and ratio of RIfrom the DVP on 
the left hand and the right hand. 
5.4.3 Discussion 
Direct infusion of GTN into the brachial artery significantly increased 
total forearm blood flow in the infused arm compared to the non-infused arm but 
had no effect on the ratio of RI in the infused/non-infused an-n. The highest dose 
of GTN was associated with a change in RI, but this change was of the same 
amplitude in both arms, suggesting that this was due to a systemic rather than a 
local effect. This suggests that the contour of the DVP is not detennined by local 
effects in the ann. 
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5.5 Study 2: Influence of vasoactive drugs on RI and PWV 
5.5.1 Methods 
The influence of GTN, a vasodilator and angiotensin 11, a vasoconstrictor5 
on the DVP was measured in 10 normotensive subjects (age: 31 ± 6.4 yrs, blood 
pressure: 120±13 / 62±4 mmHg, heart rate: 62±9 bpm, mean±SD). Subjects 
received saline vehicle, GTN and angiotensin 11 on 3 separate occasions 
according to a single-blind, randomised, 3 phase, placebo controlled, cross-over 
study. All subjects gave written consent for the study, which was approved by St 
Thomas' Hospital Research Ethics Committee. Subjects were cannulated on the 
right arm and were then allowed to rest for 30min. On the 3 separate days, 
subjects received intravenous infusions of saline for 15min and then 3 
cumulative doses of GTN (3,30 and 300 ýtg/min, David Bull Laboratories, 
Australia), angiotensin 11 (75,150 and 300 ng/min, Clinalfa, Germany), or 0.9% 
saline vehicle. The DVP and aortic PWV were measured as described in chapter 
2. The mean of 3 measurements taken 5min apart during each 15min infusion 
period was used for analysis. BP was measured before each PWV measurements 




During the infusion of saline vehicle, there was no significant change in 
HR, BP, PWV or RI. GTN decreased BP from 121±4 / 61±1 mmHg to 105±4 / 
49±1 mmHg during the infusion of the highest dose (P <0.001) (figure 36). HR 
increased from 64±4 to 80±4 bpm (P<0.0001). GTN produced a small but 
significant decrease in PWV (474 ni/s for the highest dose, P<0.05) and a dose 
dependent decrease in RI of 32 ± 4.7% (% units) at the highest dose (figure 35 
and figure 36). 
saline GTN: 3gg/min GTN: 30ptg/min GTN: 300ptg/min 
figure 35: Typical D VP after GTN in a healthy volunteer 
Angiotensin 11 increased systolic and diastolic BP from 114±4 / 59±2 to 
132±5 / 75±2 mmHg (each P<0.0001) without affecting HR. The change in PWV 
after angiotensin 11 infusion was small but significant (increase of 0.7 m/s for the 
highest dose. P<0.05). Angiotensin 11 produced a dose dependent increase in RI 
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figure 36. - Effect of GTN on bloodpressure, PWV and RI. 
P values refer to ANO VA for repeated measurements over thefull dose range 
m 
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figure 37. - Effect of angiotensinII on bloodpressure, Pwy and RI. 
P values refer to ANO VA for repeated measurements over thefull dose range 
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5.5.3 Discussion 
There is an extensive literature on the effects of vasoactive drugs on the 
contour of the pressure wave'9; '00. Vasodilators reduce the amplitude of the 
reflected wave whereas vasoconstrictors increase its amplitude. This study was 
designed to examine the effect of a vasoconstrictor and a vasodilator on the DVP. 
Local infusion of drugs produced no effect. By contrast, systemic infusion of the 
vasodilator GTN produced a dose dependent reduction of RI (figure 35 and 
figure 36) and angiotensin II, a vasoconstrictor, increased RI (figure 37). The 
drugs had the expected effects on BP with GTN decreasing and angiotensin 11 
increasing BP. Cardiac output was not measured in this study and it is possible 
that GTN reduced cardiac output by a reduction in pre-load. However, 
angiotensin 11 would also be expected to reduce cardiac output through a 
baroreceptor reflex. Because of the divergent effects of GTN and angiotensin 11 
on RI, it is unlikely that effects on IRJ were due to alterations in cardiac output. 
Another possible mechanism that could account for effects of the vasoactive 
drugs on RI is an alteration in PWV resulting in a change in the time of arrival of 
the reflected wave. However, changes in PWV were minimal (< I m/s) and this 
mechanism is also unlikely to explain the change in RI. GTN and angiotensin 11 
are known to alter pressure wave reflection as assessed by AN in the pressure 
pulse. The most likely explanation for the present findings is, therefore, that an 
alteration in the amplitude of pressure wave reflection is responsible 
for the 
change in RI of the DVP. The major difference between Alx and 
M is that AN is 
caused by the addition of the reflected pressure wave with the 
direct pressure 
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wave in early systole whereas RI is influenced by the reflected wave in 
diastole/late systole. There may, therefore, be important differences in the 
estimation of pressure wave reflection by RI and AN, AN being more sensitive 
to the direct wave. RI is thus related to the amplitude of wave reflection. In the 
following chapter, the influence of the timing of the reflected wave will be 
studied. 
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CHAPTER 6: Estimation of large artery 
stiffness from the DVP: analysis of age and 




Ageing is accompanied by increased stiffness of large elastic arteries 
leading to an increase in pulse wave velocity (pWV)8; 9; 21. Premature arterial 
ageing as detennined by an elevated aortic PWV is now recognised to be 
associated with risk factors for cardiovascular disease 
5; 16; 17; 69; 72 
. Furthermore, 
aortic PATV is an independent predictor of cardiovascular mortality in patients 
with end stage renal failure 
17 
, in hypertensive subjeCtS20; 
69, 
patients aged more 
than 70 years of age9o, and in patients with glucose intolerance and diabeteS32. 
An influence of vascular ageing on the contour of the peripheral pressure 
7-60 
and DVP in the upper limb is also well recognised ,. This change in pulse 
contour is likely to be due to an increase in large artery stiffness. An increase in 
arterial stiffness leads to an increase in PWV, decreasing the time taken for 
pressure waves reflected from the lower body to return to the aorta. 
Consequently, reflected waves arrive earlier within the cardiac cycle altering the 
contour of the pulse 104 . This raises the possibility that 
large artery stiffness may 
be assessed from the peripheral pulse, particularly from the DVP. 
6.2 Definition of SI: an index of vascular stiffness 
derived from the DVP 
The DVP is formed by the summation of a direct wave and reflected 
wave. The arm represents a common path, so the time 
delay between the direct 
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wave and the reflected wave is determined by the forward and backward 
propagation time along the aorta and large arteries (i. e. from the aorta to the 
major site of reflection and back). It is, however, not possible to measure the 
exact time of arrival of the reflected wave but the peak to peak time (PPT, figure 
38), the time from the peak of the direct wave to the peak of the reflected wave 
should be a good approximation. In a previous small study (n=20), PPT was 
shown to be closely correlated with the pressure wave transit time from the root 
of the subclavian artery to the aortic bifurcation'9 (R=0.75, P<0.0001, figure 39). 
PPT was approximately 4 times the subclavian-iliac bifurcation transit time. 
Reflections arise from multiple sites but, to a first approximation, can be seen as 
a single reflected wave coming from an apparent site of reflection. O'Rourke et 




difference in path length of the reflected wave is hence approximately twice the 
distance from the aortic root to mid-thigh, approximately 4 times aortic length. 
This is close to the ratio observed between PPT and aortic transit time. The 
relation between PPT and aortic transit time thus supports the idea that PPT is a 
measure of the time taken for the direct wave to propagate to the site of reflection 
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figure 39: Correlation between PPT and aortic transit time 
R=0.75, P< 0.0001 (from Chowienczyk et al. 29) 
Peak to peak time (PPT) is thus an estimate of transit time from the aortic 
root to the point of reflection. PWV over this path could be estimated from path 
length/PPT. It is difficult to assess the exact length of the arterial path but, to a 
first approximation, it will be proportional to the height of the subject. For this 
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reason, a stiffness index (SI), was defined from the DVP as: Sl = PPT - 
Sl is 
hence expressed in m/s, in the same units as PWV, another measure of arterial 
stiffness. 
6.3 Aims 
The aim of this chapter was to examine the relationship of SI to age and 
BP in asymptornatic subjects and compare it with measurements of aortic PýW. 
To examine the sensitivity or lack thereof of SI to changes in tone of small 
arteries, glyceryl trinitrate (GTN) was used. GTN is known to markedly 
influences vascular tone 
94 but has little effect on large artery pWV 
64 
6.4 Methods 
Aortic PVvV was determined by measuring carotid to femoral transit time 
using the Sphygmocor (AtCor, Australia) as described in section 2.3. The 
distance between the sternal notch and femoral artery was used to estimate the 
path length between the carotid and femoral arteries. 
Reproducibility of Sl and PWV was assessed in 8 healthy men (aged 22 
to 51 years) by obtaining 3 measurements separated by one week but otherwise 
under identical conditions. Sl and PWV were detennined in 87 asymptomatic 
subjects (29 women, mean age 47 years, range 21 to 68 years). No subject 
had a 
previous history of cardiovascular disease and none were receiving vasoactive 
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drugs. All were screened by physical examination and routine biochemistry. 
Subject characteristics are tabulated in table 3. 
Mean SD Range 
Age (years) 47 13.8 21 -68 Female/Male 29/58 
Smokers/Non-smokers 15/72 
BMI (Kg/M2) 25 3.6 18 -36 Diastolic BP (mmHg) 74 9 51 -92 Systolic BP (mmHg) 125 15 91 -178 
T-cholesterol (mmol/L) 5.1 1.1 3.1 -7.6 
Triglycerides (mmol/L) 1.6 1.0 0.5 -4.7 
HDL-cholesterol (mmol/L) 1.5 0.4 0.8 -2.5 
table 3: Subject characteristics 
Following at least 15 minutes resting semi-supine, 3 consecutive 
measurements of Sl and aortic PVvV were made. BP was taken as the mean of 3 
measurements obtained using a mercury sphygmomanometer. Mean arterial 
pressure (NIAP) was calculated from diastolic pressure plus one third of the pulse 
pressure. 
Effects of vasoactive drugs on SIDvp and PWV 
The contour of the DVP is markedly influenced by tone in muscular 
arterieS29. If SI is to provide a useful measure of stiffness in large elastic arteries 
it is important to establish to what extent it is sensitive to changes in smooth 
muscle tone. Effects of the vasodilator GTN were therefore examined in 9 
healthy normotensive men aged 23 to 45 years. Subjects attended on two days 
according to a single blind, randomised, 2-phase, placebo controlled crossover 
100 
study design. Following 30 min resting supine, subjects received an intravenous 
infusion of saline for 15 min and then, on separate days, intravenous infusions of 
GTN (3,30 and 300 ýtg/min, each dose for 15 min) and 0.9 % saline vehicle. 
PWV and SI were determined at 5 min intervals during the baseline period and at 
the end of each 15 min infusion of drug/vehicle. 
The above protocols were approved by St Thomas' Hospital Research 
Ethics Committee and all subjects gave informed consent. 
Statistics 
Subject characteristics are presented as means±SD, other results as 
means±SE. Reproducibility was expressed as the mean WSD and WCV (see 
section 2.5). Associations between SI and age, BP and total serum cholesterol 
and between MAN and these variables were examined using univariate and 
multiple regression analysis. Because of co-linearity and because SBP and pulse 
pressure are influenced by arterial stiffness the only BP measurement used in 
multiple regression analysis was NIAP. Effects of drugs on haemodynamic 




The mean value of SI in all subjects (8.4 m/s, n=87) was of similar 
magnitude to that of aortic PWV (9.3 m/s). The mean within-subject standard 
deviations of Sl and PWV in the subset of subjects who participated in the 
reproducibility study (n=8) were 0.062 m/s and 0.068 m/s respectively. Within- 
subject coefficients of variation were 9.6% and 8.8% for Sl and PWV 
respectively (P = NS). 
6.5.2 Relationship between SI, aortic PWV, age and blood 
pressure 
Typical DVP traces in subjects of differing age are shown in figure 40. SI 
was correlated with PVvrV (R=0.65, P<0.0001). A slightly higher correlation was 
obtained between PPT and aorto-femoral transit time (R=0.70, P<0.0001). By 
univariate analysis SI was significantly correlated with age (R=0.67, P<0.0001), 
SBP (R=0.32, P<0.01), DBP (R=0.48, P<0.0001), NMP (R=0.45, P<0.0001) and 
total cholesterol (R=0.41, P<0.01) but not with pulse pressure. PWV was 
significantly correlated with age (R=0.67, P<0.001), SBP (R=0.47, P<0.0001)5 
DBP (R=0.44, P<0.0001), MAP (R=0.50, P<0.0001) and correlated weakly with 
pulse pressure (R=0.25, P<0.05) but not with total cholesterol. 
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Multiple regression analysis demonstrated SI and PWV to be 
independently correlated with age and MAP (figure 41, R=0.69 and R=0.71 for 
SI and PWV respectively, each P<0.001 for age and P<0.05 for MAP). 
Regression coefficients relating SI and PWV to age (0.86 and 0.80 m. s-1. years-1 
for SI and aortic PV; V respectively) and to MAP (0.042 and 0.042 m. s-l. mmHg-1 













figure 40: Typical digital volume pulse (D VP) waveforms 
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figure 41. - Association of SI and P WV with age and MAP 
6.5.3 Effects of GTN on Sl and aortic PWV 
- SO 
During intravenous infusion of saline vehicle there was no significant 
change in HR, BP, SI, or PWV. GTN decreased BP from 125±5/62±2 to 
109±4/48±1 (P<0.001). GTN produced profound changes in the height of the 
diastolic peak of the DVP relative to the systolic peak (figure 42) reducing the 
second peak to systolic peak reflection index (RI) from 64±3 to 29±6% 
(P<0.0001). Effects on Sl were relatively modest and of comparable magnitude 
to those on PWV (figure 43). GTN decreased Sl by 0.9 m/s (from 6.5±0.19 at 
baseline to 5.3±0.27 m/s, P<0.001) at the highest dose and PWV by 0.9 m/s 
(from 8.1± to 7.2 m/s, P<0.05) at the highest dose. 
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b 
Saline GTN 3 ýtg/rnin GTN 30 ýLg/rnin GTN 300 ýtg/min 
figure 42: Influence of GTN on SI 
Effects of intravenous infusions of glyceryl trinitrate (GTN) on the digital volume pulse (D VP) in 
a healthy subject. The major change is the height of the diastolic component of the waveform 
(assessed by the reflection index RI=alb) rather than time between the systolic and diastolic 
peaks (PPT) and hence in the stiffness index (SI). 
RI 
GTN 3 ýtg/min 
GTN 30 ýtg/min 
GTN 300 ýtg/min 
figure 43: Haemodynamic changes after GTN 
Mean changefrom baseline(n=9) in mean arterial pressure (MAP), stiffness 
index (SI), aortic 
pulse wave velocity (P WV) and reflection index (RI) 





A number of indirect and direct measures of large artery stiffness have 
been proposed. PWV is inversely related to arterial distensibility by the 
Bramwell-Hill equation 21. Its determination over the carotid-femoral region is the 
most direct measurement of large artery stiffness that has been applied in large 
numbers of subjects. The shape of the arterial pulse is detennined by pulse wave 
velocity. On the aortic pressure pulse, the augmentation index (AIx) has been 
proposed as a measure of arterial stiffness' 
12; 146 
. However, although AN exhibits 
a reasonable correlation with PWV under basal conditions, vasoactive drugs 
cause it to change markedly and independently of pWV64. 
Sl can not be expected to provide identical infonnation to PWV. SI relies 
on the assumption that arterial path length to the major sites of reflection is 
proportional to subject height. The contour of the peripheral pulse is complex 
and SI is likely to be influenced by factors other than PWV such as the 
characteristics of ventricular ejection and the exact distribution of sites of 
pressure wave reflection. Furthermore, since the major site of pressure wave 
reflection lies distal to the aorta, Sl will be influenced by the distensibility of 
these arteries in addition to that of the aorta. The detennination of PWV depends 
on the accuracy with which the difference in arterial path length from the carotid 
to the femoral artery can be estimated. In elderly people, surface measurements 
may underestimate arterial length, as the artery becomes more tortuous. 
The 
distance is also difficult to estimate accurately in obese subjects. 
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Despite these reservations the correlation between SI and PWV is 
striking, being higher than that reported for other widely used indices of arterial 
stiffness such as systemic arterial compliance (SAC) for which the correlation 
with PVYIV has been reported as 0.47 in healthy subjeCtS73 .A slightly higher 
correlation was observed between transit time measured directly and PPT 
consistent with some inaccuracy in the determination of length contributing to 
the difference between Sl and PWV. The similarity of the relationship between 
SI, age and BP with that between PWV, age and BP supports the concept that SI 
and PWV are influenced by similar factors. The similarity of these relationships 
suggests that variation between SI and PWV relates at least in part to 
experimental errors inherent in determining one or both of these measurements 
rather than to a systematic difference. 
In addition to the timing of reflected pressure waves, the contour of the 
arterial pulse is influenced by the amplitude of wave reflection. Pressure wave 
reflection is dependent on vascular tone of small muscular arteries and 
vasoactive drugs may influence reflection independently of effects on large 
artery stiffness and hence PWV. To investigate whether such changes in 
reflection influence SI, effects of GTN on Sl and PWV were examined. As 
expected, GTN caused large changes in the contour of the DVP but these were 
limited mainly to an alteration in the height of the diastolic component so that 
changes in PPT and hence SI were modest and of comparable magnitude to those 
of PVvIV. This supports the concept that SI is influenced predominantly by large 




In conclusion, SI is correlated with PVN and varies with age and BP in 
similar manner to PWV. It is influenced by vasoactive drugs to a similar extent 
as is PNW. It may be a valuable index to assess large artery stiffness at least in 
asymptomatic su ects. 
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CHAPTER 7: Comparison of direct and 
second derivative analysis of the DVP 
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7.1 Background 
Studies presented in chapter 5 and 6 suggest that the DVP can be used to 
assess effects of vasoactive drugs and of ageing. Interest in this application has 
also received much attention by investigators in Japan. Here, however, a 
completely different approach to the analysis of the DVP has been taken. 
Features of the second derivative of the DVP (the "acceleration 
photoplethysmogram", d2 DVP/dt 2) have been used to study the influence of 
vasoactive drugs 131; 132 and the association with age 19; 45; 52; 131; 133 , 
blood pressure 
(BP) 19,45 and pulse wave velocity (pNW)45 and on the DVP (see section 1.4). 
Typically, the d2 DVP/dt2 comprises 5 waves called the a, b, c, d and e waves as 
shown in figure 44. The relative heights of these waves (b/a, c/a, d/a and e/a 
ratios), particularly the d/a ratio, have been related to age, BP and actions of 
19; 133 
vasoactive drugs 
The main problem with this approach is that interpretation of these 
indices is not straightforward and it is difficult to relate them to biornechanical 
properties of the cardiovascular system. 
7.2 Aims 
The aim of this study was to compare the indices RI and Sl derived from 
the DVP with indices derived from the d2 DVP/dt 
2. The repeatability and 
reproducibility of these indices, their association with age and change 
in response 
to vasoactive drugs were studied. 
III 
Digital Volume Pulse 
111 derivative 
2 nd derivative 
or Acceleration 
Plethysmogram 
figure 44: 2 nd derivative of the D VP 
Definition of the a, b, C, d and e waves 
7.3 Methods 
The DVP was measured from the index finger of the right hand as 
described in section 2.2. Measurements were obtained with subjects supine after 
at least 20 min resting in a quiet temperature controlled clinical laboratory. DVP 
wavefonns were recorded over at least 10 cardiac cycles and averaged to obtain a 
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single wavefon-n from which RI and SI were calculated as previously described 
in sections 5.2 and 6.2. 
To calculate the b/a, c/a, d/a and e/a ratios, the DVP signal was digitally 
filtered (low pass filter to remove the high frequency noise amplified by 
differentiation) and then differentiated twice to obtain the second derivative 
(d 2 DVP/dt2) . The a-wave was defined as the maximum of the d2 DVP/dt2 . The b, 
c, d and e waves were detennined as the 1", 2 nd ,3 
rd and 4h consecutive zero- 
crossings ote3 rd derivative after the a-wave (see figure 44). Cardiac cycles for 
which the a, b, c, d or e waves could not be identified were not analysed. The 
indices a, b, c, d and e were determined for each cardiac cycle and mean values 
from a minimum of 10 cycles used for analysis. Takazawa et al. described an 
ageing index defined as the (b-c-d-e)/a ratio 133 . This index was also calculated. 
As differentiating is a high-pass filter process, the cut-off frequency of 
the low pass-filter could influence the shape of d2 DVP/dt2 and in particular the 
relative height of the a, b, c, d, and e-waves. To test this, 3 different cut-off 
frequencies for the low pass filter were used: 10,12 and 16 Hz. Previous 
investigators have used cut-off frequencies of 10 Hz 19 and 16 Hz 
132 
The digital filter used was a Remez filter with passband frequency (Fp) 
and stopband frequency (Fs, as defined in figure 45) set to IOHz, 12Hz or 16Hz 
and 12.5,14.5 or 18.511z respectively. 
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OdB 
figure 45. - Remez digitalfilter 
Fp : Passbandftequency, Fs : Stopbandfrequency 
7.4 Study 1: repeatability and reproducibility 
7.4.1 Methods 
Eight healthy men (age: 31.5 ±7 yrs, BP: 121±14 / 62±5 mmHg, means ± 
SD) attended on 4 different occasions separated by at least 3 days. The DVP and 
d2 DVP/dt2 were obtained during 3 consecutive recordings after at least 20 min 
rest in a temperature control room. 
Repeatability was assessed as the mean within-subjects standard 
deviation (WSD) of measurements obtained on the same day and reproducibility 
as the WSD of measurements made on different days. Repeatability and 
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reproducibility were also expressed as the within subject coefficient of variation 
(WCV) as described in section 2.5. 
For measurements highly correlated with age (SI and d/a), the WSD was 
expressed in equivalent years of vascular ageing as determined from the slope of 
the regression lines relating SI to age and d/a to age. 
WSD and WCV were calculated for indices obtained after the 3 different 
filters (IOHz, 12Hz and 16Hz) in order to investigate the influence of the cut-off 
frequency and to choose the optimum cut-off frequency for further analysis. 
7.4.2 Results 
As shown in figure 46, the cut-off frequency used in the filtering process 
significantly affects the values of the indices b/a and e/a derived forin the 
d2 DVP/dt 2. Values of c/a and d/a are not so affected by the cut-off frequency 
used. RI and Sl were independent of the cut-off frequency (values differed by 
less than 0.1%). Table 4 shows the reproducibility and the repeatability values of 
RI, SI and the indices derived from the d2 DVP/dt2 after 1OHz filtering. The 
repeatability and reproducibility of RI and SI were not affected by the cut-off 
frequency of the digital filter. However, indices derived from the d2 DVP/de were 
less repeatable and less reproducible after filtering at 12Hz and 16 Hz than after 































figure 46: d2DVPldt2 indices obtained after different low-passfilters 
Mean bla, cla, d1a and ela indices using 10,12 and 16Hz low-pass filtering. 
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1OHz 12Hz 16Hz 
1OHz 12Hz 16Hz 
Repeatability 
mean WSD WCV 
Reproducibility 
mean WS D WCV 
b/a -0.79 0.04 4.88% -0.79 0.05 5.96% 
c/a 0.06 0.02 33.64% 0.06 0.05 80.27% 
d/a -0.08 0.02 20.76% -0.08 0.03 43.91% 
e/a 0.19 0.02 12.23% 0.19 0.04 21.86% 
sl 6.33 0.28 4.39% 6.23 0.32 5.08% 
RI 62.99 2.93 4.65% 62.99 8.69 13.80% 
table 4: Repeatability and reproducibility 
Repeatability (measurements on the same day) and reproducibility (measurements on separate 
days) of indices derivedfrom the D VP and d2D VPldt2after I OHzfiltering 
7.4.3 Discussion and conclusion 
The differentiation process used to obtain the d2 DVP/dt2 increases high 
fi-equency noise and filtering is necessary to eliminate this. It has been shown 
that most of the information in the arterial pulse is contained in the first 10 
harmonics'21 
. 
For a HR of 60 beats per minutes, this means that most the 
information of the DVP is below lOHz. However, the 2 nd derivative is affected 
more by higher frequencies. Bortolotto et al. used a lOHz low pass-filter'9 when 
assessing the d2 DVP/dt2 whereas Takazawa et al. used a 16 Hz filter 132 . 
The 
results of this study show that the cut-off frequency does affect the indices 
derived from the d2 DVP/dt2 (the b/a, c/a, d/a and e/a ratios) whereas RI and SI 
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from the DVP are not influenced by this. The detection of a, b, c, d and e wave is 
frequency dependent. However for d/a (the most used index) similar values are 
obtained using filter cut-offs of 10 and 16Hz. With higher frequency cut-offs, 
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figure 47: Example of the dDVP/d? after different low-passfilters: 
16Hz low pass (green), 12Hz (red) and I OHz (blue). 
The best reproducibility and repeatability for the indices derived from the 
d2 DVP/dt2 were achieved with the I OHz filter. Subsequent studies were, 
therefore, done using this filter. 
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The WCV for the d2 DVP/dt2 indices was high but with the mean value of 
these indices being close to zero, the WCV is difficult to interpret and the WSD 
provides more information. Of the various d2 DVP/dt2 indices, d/a was the most 
reproducible (lowest WSD). It was, however, more variable than RI or SI 
probably because the d2 DVP/dt2 is more affected by high frequency noise. Sl and 
d/a are highly correlated with age (see section 7.5). It is therefore possible to 
express the WSD of SI and d/a as an equivalent change in vascular age. A WSD 
of 0.32 for SI represents 2.1 years of vascular ageing whereas for d/a it represents 
5.4 years. So SI is less variable than d/a. 
In conclusion, the cut-off frequency significantly influences the b/a, c/a, 
d/a and e/a indices derived from the d2 DVP/dt2 whereas it does not affect RI and 
SI. The repeatability and reproducibility of b/a, c/a, d/a and e/a are relatively 
poor compared to RI and SI. 
7.5 Study 2: Association with age and blood pressure 
7.5.1 Methods 
The DVP and d2 DVP/dt 2 were obtained in 124 men aged from 20 to 74 
years, with no history of diabetes or cardiovascular 
disease other than 
hypertension (9 out of 24 had a previous diagnosis of hypertension). No subjects 
were taking vasoactive drugs. Subjects rested supine 
in a warm room for at least 
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20 min, and then 3 recordings, each of 20s, of the DVP were made at 5 minute 
intervals. d2 DVP/dt2 was obtained as described in section 7.1. 
7.5.2 Results 
Correlation coefficients for b/a, c/a, d/a, e/a, RI and Sl with age, systolic 
blood pressure (SBP), diastolic blood pressure (DBP) and mean blood pressure 
(MAP) are surnmarised in table 5. SI was strongly associated with age and BP. 
Of the d2 DVP/dt2 indices, d/a showed the strongest association with age (figure 
48) and BP with correlation coefficients of similar magnitude to those for SI. 
Multiple regression analysis showed both d/a and SI to be independently 
correlated with age and MAP (each P<0.05). The coefficient of correlation for 
the ageing index, (b-c-d-e)/a, described by Takazawa et al. 133 with age for the 
data in this study was 0.654 (p<0.001). 
b/a cla d/a e/a SlDVP Rl DVP 
age 0.51 -0.53 -0.66 0.08 0.63 0.24 
SBP 0.19 -0.17 0.39 0.17 0.48 0.08 
DBP 0.18 -0.24 0.57 0.28 0.68 
0.28 
MAP 0.16 -0.13 0.41 0.23 0.51 
0.18 
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figure 48: a) SI versus age b) d1a versus age in 124 men. 
7.5.3 Discussion and conclusion 
Results of this study confirm those in chapter 6, that SI is strongly 
correlated with age and BP. Despite the influence of vasoactive drugs on RI as 
described in chapter 5, RI was only poorly correlated with BP. Findings from this 
study with regard to the second derivative indices are broadly in agreement with 
133 52 
those of Takazawa et al. and Imanaga et al. : b/a ratio increases with age, 
whereas c/a and d/a decrease with age. However no relationship between e/a and 
age was observed. The correlation reported by Takazawa et al. was, however, 
relatively small (R = -0.25) with 600 subjects. The present study in 124 subjects 
may be too small to find a weak relationship between e/a and age. 
Takazawa et al. found a strong correlation with the ageing index and age 
(R=0.80). In the present study, the ageing index was slightly less correlated with 
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age (R=0.65) than the d/a ratio (R=0.66). As the ageing index incorporates e/a 
and no relation between age and e/a ratio was found, the ageing index seems to 
offer no advantage over the d/a ratio in assessing ageing, at least in asymptornatic 
subjects. This may not be the case in subjects with cardiovascular diseases. 
Takazawa et al. 133 found an increased ageing index (p<0.01) in patients with 
hypertension, diabetes, ischemic heart disease and hypercholesterolemia 
compared with age matched controls. Bortolotto et al. 19 found patients with 
atherosclerotic alterations also had a higher ageing index (p<0.001). In the 
present data, the small number of hypertensive subjects did not allowed a 
comparison of differences in the ageing index between hypertensive and 
normotensive men. 
The indices b/a, c/a and d/a from the d2 DVP/dt2 are correlated with age 
and only d/a is correlated with BP as well. These results are in agreement with 
those of Takazawa et al. 
132; 133 
. The correlation of 
SI with age and BP is similar to 
that between d/a, age and BP. 
7.6 Study 3: effects of vasoactive drugs 
7.6.1 Methods 
10 healthy volunteers (31 ±6 years) attended on 3 days according to a 
single blind randomised, 3-phase, placebo controlled crossover study 
design. 
After 20min rest supine, saline was infused and the DVP was recorded 3 times at 
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5 minutes intervals. The DVP was then recorded during infusion of angiotensin 
11 (75,150 and 300 ng/min, Clinalfa, Ldufelfingen, Germany) or of GTN (3,30, 
300 ýtg/rnin, David Bull Laboratories, Australia) and saline vehicle. The GTN 
data of one of the volunteers was discarded due to poor quality. The d2 DVP/dt2 
was calculated as described in section 7.3. 
7.6.2 Results 
During intravenous infusion of saline vehicle, there was no significant 
change in HR, BP, RI, Sl or d2 DVP/dt2 indices. Angiotensin 11 produced a dose 
dependent increase in MAP from 78±8 to 93±8 mmHg at the highest dose 
(P<0.001), an increase in FJ (P<0.01, figure 49) and a decrease in d/a (P<0.001, 
figure 49). GTN produced a dose dependent decrease in MAP from 82±8 to 67±4 
mmHg (P<0.001), and a decrease in Rl (P<0.001, figure 50) but d/a did not 
change in a dose dependent manner (figure 50). The other d2 DVP/de indices b/a, 
c/a and e/a did not show a consistent response to angiotensin 11 and GTN. The 
vasoactive agents produce a change in Sl of 2.6m/s for angiotensin 11 and - 
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figure 50. - Effects of glyceryl trinitrate (GTN) on a) RI and b) d1a 
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7.6.3 Discussion and conclusion 
d/a was the only d2 DVP/dt2 index to show a consistent change in response 
to angiotensin 11 and to the lower doses of GTN. This is consistent with a study 
by Takazawa et al. 133 An exact quantitative comparison between the present 
study and the study by Takazawa et al. 133 is not possible because their study was 
perfon-ned in older cardiac patients using different doses of drugs and different 
routes of administration. 
Of the various d2 DVP/dt2 indices, d/a was also the most reproducible (see 
section 7.4) with the lowest WSD. RI was, however, more repeatable and 
reproducible and showed a consistent response to both vasoactive agents. The 
use of the 2'd derivative does not seems to improve the detection of vasoactive 
change in the vasculature. 
7.7 Overall conclusions about the comparison of the 
DVP and the d2 DVP/dt2 
Changes in the DVP associated with ageing and vascular disease have 
been recognised for many years 36 . The approach to quantitating 
these changes 
has differed with the use of measurements taken directly from the DVP or from 
the d2 DVP/dt2 . The second 
derivative has the potential advantage of identifying 
subtle changes in the contour of the DVP. The drawback of such an approach 
is 
that the physical meaning of the indices derived from the d2DVP/de is not 
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obvious. Furthermore, values of indices derived from the d2 DVP/dt2 depend on 
the cut-off frequency of the filter used to eliminate noise. Using the second 
derivative might help to detect particular characteristics of the waveform, but it is 
sensitive to filtering characteristics and/or noise. 
In section 5.1, an interpretation of RI and SI in terms of pressure wave 
reflection and large artery stiffness was presented. In the present study, RI 
showed no significant correlation with age but was markedly influenced by 
angiotensin 11 and GTN in a dose dependent manner, consistent with an effect of 
these drugs on the tone of small arteries. Of the d2 DVP/dt2 indices, d/a was the 
most reproducible, was the most highly correlated with age and showed a 
consistent response to angiotensin 11. This might explain why it is the ratio the 
most used by other investigators. However, d/a did not change in a dose response 
manner in response to GTN. The influence of angiotensin 11 on d/a and the 
correlation of d/a with age suggests that d/a is influenced both by large and small 
arteries. As a measure of vascular tone, therefore, d/a may be more difficult to 
interpret than RI. 
As expected for an index of large artery stiffness, SI was strongly 
positively correlated with age and BP. d/a was also highly negatively correlated 
with age. The relative merits of these indices in detecting vascular ageing will be 
mainly determined by their degree of change relatively to their reproducibility 
and their sensitivity (or lack of sensitivity) to confounding factors. Comparison 
of repeatability and reproducibility of d/a and SI is difficult because mean values 
of d/a are close to zero. For this reason the WSD was expressed as an equivalent 
change in vascular age. Variability of SI as assessed by WSD on different days 
was equivalent to 2.1 years of vascular ageing whereas that of d/a was equivalent 
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to 5.4 years. Ideally, SI and d/a should be compared to PWV. This was not 
possible due to time constraints. However the correlation of SI with PWV in 
another group of subjects is presented in section 6.5.2 and the coefficient of 
correlation was 0.67 (P<0.0001). Hashimoto et al. have compared d/a with aortic 
PWV,, a measure of aortic stiffnesS45 . Although PWV and d/a are both correlated 
with age and BP, they were only weakly correlated to each other (R=0.24) 
whereas a strong correlation between Sl and PWV was observed (R=0.65, see 
section 6.5.2). Changes in SI in response to vasoactive drugs were small and 
could be explained by changes in BP. By contrast, d/a changed to a greater 
degree. The better reproducibility of SI compared to d/a, less marked change 
after vasoactive agents but similar correlation with age and BP suggest that Sl 
may be as useful if not a better measure of vascular ageing in healthy men. 
In conclusion, in asymptomatic volunteers, RI may be a better index to 
track the effects of vasoactive drugs than indices such as d/a from the second 
derivative. Sl is equally strongly associated with age as d/a, but shows less 
variability and thus may be a more reliable index of vascular ageing. The use of 
the second derivative may not be necessary to interpret useful characteristics of 
the DVP. 
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CHAPTER 8: Clinical Applications 
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Potential uses of the DVP as a simple tool to investigate vascular function 
are explored in this chapter. Applications examined are: endothelial function, 
vascular function in pregnancy and epidemiological screening using the example 
of the association of vascular function with birth weight. 
8.1 Endothelial function 
8.1.1 Background 
With the recognition that atherosclerosis is initiated by injury to the 
endothelium, there has been much interest in endothelial-derived substances as 
markers or mediators of atherogenesis. Endothelium derived nitric oxide (NO) 
has received most attention. In addition to being an important vasodilator, NO 
has anti-atherogenic properties, including inhibition of the expression of 
adhesion molecules, inhibition of platelet adhesion and aggregation and 
inhibition of vascular smooth muscle proliferation 93 . Decreased availability of 
endothelium-derived nitric oxide (NO) is thought to be of major importance in 
the initiation and progression of atherosclerotic vascular disease 102 . Impaired 
enclothelium-dependent vasodilation mediated by NO is observed at the earliest 
stages of vascular disease and, in the presence of most recognised risk factors for 
vascular disease, is evident before development of clinical sequel'. In such 
subjects endothelium-dependent vasomotor function is predictive of future 
ischaemic events' 
17; 122; 130 
. Interventions that reduce the progression of vascular 
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disease such as lipid lowering drugs are associated with improved endothelial 
function'. The potential for NO to play a causal role in the beneficial effects of 
such interventions is demonstrated by animal models where 
pharmacological24; 103 or genetiC26; 67 modulation of NO synthase is seen to 
influence atherogenesis. Existing techniques for assessing endothelial function 
involve intra-arterial injection of an endothelium-dependent vasodilator (usually 
acetylcholine) into a local vascular bed such as the forearm or involve measuring 
the vasomotor response to a physical stimulus such as an increase in shear stress. 
The only accepted non-invasive technique involves measuring dilation of the 
brachial artery in response to an increase in blood flow generated by reactive 
hyperaernia 25 . The change in brachial artery diameter is at the limit of resolution 
of high quality ultrasound imaging systems. The technique requires expensive 
equipment and extreme attention to detail: reliable results can only be obtained 
by an ultrasonographer with extensive experience in the method. There is thus a 
real need for a simple and robust test of endothelial function. The sensitivity of 
the DVP to exogenously administered NO donors (as described in sections 1.4 
and 5.1) raises the possibility that it should also be sensitive to stimulated NO 
release from the endothelium and hence, given an appropriate stimulus, could be 
used as a simple test of endothelial function 140 . Work in the 
department of 
clinical pharmacology at St Thomas' Hospital has previously shown that the P2- 
agonist salbutamol acts to stimulate NO release 35 . The aim of the present study 




To deten-nine whether salbutamol produces a similar change in the DVP 
to GTN and to investigate whether the response to salbutamol is impaired in 
subjects with type 2 diabetes, a group known to have endothelial dysfunction 
8.1.3 Methods 
20 healthy controls (n=20) and 20 type 11 diabetes (n=20) were recruited 
with the approval of St Thomas' Hospital Research Ethics Committee. Patients 
with type-11 diabetes were recruited from the diabetic clinic of St-Thomas' 
hospital. They were managed by diet alone or by diet plus oral hypoglycaemic 
therapy. No patients had complications other than background retinopathy. 
Control non-diabetic subjects were recruited concurrently and were similar in 
tenns of age and gender distribution. Subject characteristics are shown in table 6. 
After 30min rest supine, DVP, HR and BP were measured at 5 minutes interval. 
The DVP was measured as described in section 2.2. GTN (500 ýtg sublingually) 
was then administered and BP and DVP measurements were made 3 min after 
GTN. Twenty minutes later, when DVP and BP returned to baseline, salbutamol 
(400 ýtg) was given by inhalation through a spacer. DVP and BP were measured 







Gender (M/F) 15/5 13/7 
Smokers / Non-smokers 4/16 5/15 
Age (years) 44 ± 6.9 48 10 
SBP (mmHg) 123 17 131 21 
DBP (mmHg) 71 13 78 12 
BMI (k g/M2) 24 2.5 28 4.7 
Glucose (mmol/L) 4.8 0.6 10.3 5.3 
HbA Ic (%) 4.9 0.6 7.7 2.0 
T-Chol (mg/dl) 189 ± 31 201 46 
Triglycerides (mg/dl) 115 ± 71 230 186 
HDL (mg/dl) 54 ± 12 46 12 
table 6: Subjects Characteristics 
P<0.05, data are presented as mean ± SD 
8.1.4 Results 
The effect of salbutamol and GTN on HR and BP were similar in the 2 
groups (see table 7). At baseline, values of RI were similar in controls and 
patients with diabetes. Salbutamol and GTN both produced a fall in RI. The 
response to GTN was similar in controls and patients with diabetes but that to 
salbutamol was significantly less in patients with type 11 diabetes (see figure 5 1). 
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control subjects diabetics 
GTN 9.8 ± 1.6* 7.1 ± 1.2* 
AHR (bpm) 
Salbutamol 6.5 ± 1.2* 5.6 ± 1.2* 
GTN 0.3 3.0 1.6 3.1 
ASBP (mmHg) 








table 7: Changes in heart rate and bloodpressure after GTN and salbutamol 
JHR: change in heart rate; JSBP: change in systolic bloodpressure; ADBP change in diastolic 
blood pressure (*P< 0.05) 
30- - 
P= NS P=0.02 
77 F-7 
20- - 
c co lo- - ... 
0 
GTN salbutamol 
figure 51: Change in RI in control and diabetic subjects 
Change of R-[ (016) from baseline after sublingual GTN and inhaled salbutamol in controls 
(dashed lines) and in type II diabetes (solid lines) 
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8.1.5 Discussion 
GTN produces vasodilation through its metabolism in vascular smooth 
muscle to nitric oxide or a nitrosothiol3l. Salbutamol stimulates nitric oxide 
release from the enclothelium through the L-arginine-NO pathway. Salbutamol 
should therefore have similar effects on the DVP as GTN 140 . This study confinns 
that both salbutamol and GTN reduce RI and confirms observations from 
animals work. In patients with endothelial dysfunction, characterised by an 
abnonnal L-arginine-NO pathway, such as those in type 11 diabetes, a blunted 
response to salbutamol would be expected. Results of the present study support 
this and suggest that the DVP response to salbutamol might be used as a simple 
test of endothelial function. Other investigators have explored this concept using 
the pressure pulse rather than the DVp47; 
74; 75; 144. Wilkinson et al. 
144 have 
examined the response of aortic AN (obtained by transformation of the radial 
pulse) to salbutamol. They found this to be impaired in hypercholesterolaemic 
patients compared with normo-cholesterolaemic controls. They also 
demonstrated a correlation between the AN response to salbutamol and forearm 
blood flow response to brachial artery infusion of acetylcholine (a standard test 
of endothelial function). As described in chapter 4, the pressure pulse is closely 
related to the DVP but the aortic AN relies on a transfer function (see chapter 3) 
and is influenced by factors (HR, PWV, ejection pattern) other than vasodilation. 
RI is measured on the diastolic part of the DVP and may be more closely related 
to vasodilation (see section 5.5). A similar approach, based on examining 
response of the radial AIx to salbutamol or terbutaline, has been shown to be NO 
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dependen t47; 74; 75 . Hayward et al . 
47 have also shown that the radial AN response 
to salbutamol can distinguish between subjects with coronary diseases and 
normal controls subjects. This reinforces the observation made in chapter 3, that 
similar information can be obtained from the radial and aortic AN. 
In conclusion, the DVP response to salbutamol has potential as a simple 
test of endothelial function. To fully assess this, its reproducibility and sensitivity 





Normal human pregnancy is characterised by an increase in cardiac 
output and a reduction in peripheral arterial resistance, which occurs from the 
12 th week of gestation. The mechanism involved in the reduction of peripheral 
resistance is unknown although increased endothelial synthesis of nitric oxide 
has been proposed' 18. Pre-eclampsia is a disease process arising usually in the 2 nd 
half of pregnancy and is characterised by hypertension, proteinuria and 
sometimes oedema. Pre-eclampsia complicates 5 to 10% of pregnancies and is a 
major cause of maternal and foetal morbidity and mortality' 37 . The only cure is 
delivery. The management of pre-eclampsia starts with screening for the 
development of hypertension and proteinuria as these are usually not associated 
with symptoms. Once hypertension is discovered, the patient is admitted to 
hospital for close monitoring. However, there is a high rate of false-positive 
cases (and false-negative as well) at a great cost to the Health Service. There is a 
need for an early reliable test for pre-eclampsia. Pre-eclampsia is characterised 
by an increase in peripheral resistance and pressor activity, reduced cardiac 
output and reduced perfusion of vascular beds. Present methods for measuring 
peripheral resistance and cardiac output are either labour intensive or invasive. 
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8.2.2 Aim 
The aim of this study was to investigate if DVP contour analysis, a 
simple, non-invasive and rapid method, could be used to monitor changes in 
arterial function due to pre-eclampsia. 
8.2.3 Methods 
10 women with pre-eclampsia, diagnosed according to the ISSHP 
definition 33 were studied shortly after admission, before initiation of anti- 
hypertensive treatment. Women who had diabetes and hypertension before 
pregnancy were excluded. 20 normotensive pregnant women of similar age and 
gestation were studied in the ante-natal clinic as controls. The DVP was 
measured as described in section 2.2. 
8.2.4 Results 
Subjects characteristics are tabulated in table 8. 
I 







34 ± 3.7 
36 ± 4.2 
-I 
29 ± 6.5 
28 ± 6.0 
90 ± 2.1 
84 ± 5.0 
I-- 
121 ± 4.5 
151 ± 3.1** 
I 
69 ± 2.2 
99 ± 4.6** 
table 8: Subjects characteristics 
Values are means. ±SD exceptfor heart rate and bloodpressure (means. ± SE) 
*P < 0.01, ** P< 0.001 compared to healthy pregnant women 
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RI and SI were significantly increased in women with pre-eclampsia, as 















figure 52: RI and SI in pregnancy 
RI and SI measured on the DVP in healthy pregnant women and women with pre-eclampsia 
*P<0.01, **P<0.001 compared to healthypregnant women 
8.2.5 Discussion 
These results show that both RI and SI are increased in pre-eclampsia 
compared to values in normal pregnant women. The increase in RI is consistent 
with an increase in vascular tone affecting both resistance arteries (and hence 
causing an increase in BP) and in more proximal arteries causing an increase in 
pulse wave reflection. The increase in SI may results from increased stiffness of 
the aorta and large arteries. From these data, however, it is not possible to 
detennine if the increase in Sl is a primary phenomenon or is secondary to the 
increase in BP. These results demonstrating a difference in DVP indices between 
women with pre-eclampsia and healthy pregnant women suggest that the DVP 
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Normal Pre-eclamptic Normal Pre-eclamptic 
may be useful in the prediction of pre-eclampsia. Prospective evaluation of such 
an approach will be required however to determine whether the DVP is more 
sensitive/specific in screening for pre-eclampsia compared with conventional 
monitoring of BP. 
8.3 Birth weight 
8.3.1 Background 
Barker et al. 
10-13; 86; 113 have studied the association of birth weight with 
hypertension and cardiovascular events occurring in later life. There have been 
over 80 studies demonstrating a relationship between birth weight and 
hypertension. Law et al . 
70 
and Huxley et al . 
50 in a meta-analyse suggest that 
overall, a lkg difference in birth weight corresponds to a 3.5 mmHg change in 
adult SBp70 . 
However, a recent meta-analysis in which studies have been 
weighted to account for size, suggests that the strength of the BP-birth weight 
association may have been over estimated49. An increasing risk of adult 
hypertension has also been linked to "catch-up growth"50. The association 
between birth weight and BP is seen from early childhood through to late 
adulthood. There are relatively few studies examining the relationship between 
birth weight and arterial properties. An association between arterial compliance 
and birth weight has been reported 86 in children as young as 9 years of age 
85 
. The 
DVP waveform is detennined by characteristics of the arterial tree including 
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arterial stiffness (compliance). It is possible, therefore, that the DVP exhibits a 
different contour in subjects with low birth weight. 
8.3.2 Aim 
The aim of this study was to test if birth weight is associated with a 
change in contour of the DVP in healthy adolescent subjects. 
8.3.3 Methods 
Students (n=96,48 women) aged 16 to 25 years living with their parents 
were studied with the approval of St Thomas' Hospital Research Ethics 
Committee. The majority were attending the 6 th form of a Secondary School in 
North London. BP (mean of 3 readings seated) was measured using an automated 
oscillometric method (Omron 705CP, Omron, Japan) with appropriate sized cuff. 
Birth weight was obtained by maternal recall. The PulseTrace device, described 
in section 2.2.3, was used to obtain RI and SI. The mean of 3 recordings was 
used. The relationship between BP, RI, Sl and birth weight was examined in each 
sex by regression analyses. No adjustments were made for current weight (or 
other anthropornetric characteristics) because in previous series in young adults 
there was no association between these characteristics and RI or Sl and because 
adjustment of birth weight associations for current weight and other confounding 





Mean (±SD) BP was 117±10/75±8 mmHg and birth weight 3.3±0.4 Kg. 
There was no significant correlation (in either sex) between BP and birth weight 
or between SI and birth weight. In men, RI was not significantly correlated with 
birth weight (R=O. 19, P=NS) but, in women, RI was strongly negatively 
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figure 53: Correlation of RI with birth weight 
in men (left panel, R=0.19, P= NS) and women (right panel, R= -0.52, P<0.001) 
8.3.5 Discussion 
The lack of association between BP and birth weight is consistent with the 
49 
recent analysis by Huxley et al. (our study had insufficient power to detect a 
weak association). The negative correlation between RI and birth weight 
in 
female students suggests that low birth weight may be associated with altered 
structure of small arteries (the major site of reflection). The 
lack of association 
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between RI and birth weight in men is at first sight surprising but studies in 
young adults shows that the association between birth weight and BP is stronger 
in women than in men 50 . It is possible that the growth spurt obscures birth weight 
related programming of arterial properties and such effects may be more 
apparent in young men rather than women due to the later growth spurt in men. 
In adults, low birth weight has been associated with a increase in arterial 
stiffness 86 but these results were not corrected for BP which was higher in 
subjects with low birth weight. SI is a measure of large artery stiffness and is 
determined mainly by aortic stiffness and, in this study, SI was not related to 
birth weight. In 9 year old children, carotid stiffness has been found to be related 
to birth weight 85 . This apparent conflict with the present study could relate to the 
limited power of our study to detect a weak association between SI and birth 
weight or to differences between arterial beds. 
In conclusion, the present study suggests that marked variations in the 
properties of the arterial tree as measured with the DVP, may be associated with 
birth weight in young women, independently of BP. Gender specific associations 
of birth weight with arterial properties deserve further study. 
142 
CHAPTER 9: Overall discussion 
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Characteristics of the pressure pulse contour are understood in terms of 
direct and reflected waves. Indices derived from pressure pulse contour analysis 
such as the aortic AN have been used to examine effects of ageing, hypertension, 
and vasoactive drugs. Most investigators have used the central pressure pulse 
derived by applying a transfer function (TF) to the peripheral pressure pulse. The 
analysis presented in chapter 3 suggests that a TF may not be necessary to study 
wave reflection. The peripheral pulse contains the same information as the 
central pulse regarding wave transit time and reflection. The shape of the 
peripheral pulse can be used directly to study wave reflection without 
mathematical transformation to the central pulse. A transfer function is, however, 
required to estimate central SBP. 
The DVP can be obtained more simply than the pressure pulse and with 
less training. In chapter 4, the relation between DVP and pressure pulse was 
examined and the DVP found to contain the same information than the pressure 
pulse. Like the pressure pulse, the DVP can be interpreted as the summation of a 
direct wave and a reflected wave. A reflection index, RI, has been defined to 
quantify the amplitude of wave reflection whereas timing of the reflected wave 
and hence large artery PWV is estimated with a stiffness index, SI. Data 
presented in chapters 5 and 6 suggest that these indices behave as expected. Sl is 
strongly associated with age and BP, major determinants of arterial stiffness but 
is little influenced by vasoactive drugs. By contrast, RI changes in response to 
vasoactive drugs but show little association with age and BP. Other investigators 
have analysed the second derivative of the DVP. However, as shown in chapter 
7, the benefit of using indices from the second derivative is not obvious and the 
interpretation of such indices is problematic. RI seems to be a better index to 
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track vasoactive changes, and SI correlates better with age and BP, major 
contributors to large artery stiffness. 
Although, at present, the pressure pulse is more widely used that the 
DVP, work presented in chapter 8 suggests the DVP has important potential 
clinical applications. Obtaining the DVP is very simple and rapid with no 
discomfort to the patient and requires no particular training for the operator. For 
these reasons, it could be a particularly useful tool to study arterial 
structure/function especially in situations where large numbers of subjects need 
to be studied or in subjects in whom more complicated methods are difficult to 
apply such as in children and pregnant women. Although further studies are 
required, the DVP may prove to be a useful tool to examine endothelial function, 
the arterial mechanism involve in pre-eclampsia and in the arterial modelling 
associated with low birth weight. 
Perhaps the largest and potentially the most useful application of DVP is 
the assessment of large artery stiffness. Aortic PWV has recently been shown to 
be a powerful predictor of cardiovascular mortality. If similar information could 
be obtained from the DVP, this simple measurement could be useful in identify 
patients at risk and targeting preventative treatment. Work presented in chapter 6 
shows that Sl correlates well with PWV in healthy men over the age range 21 - 
69 years. In older subjects, the inflection point on the down-slope of the DVP 
waveform may be difficult to identify. In these cases a more sophisticated 
analysis of the shape of the waveform may be required. Nevertheless, the 
correlation of SI with PWV in healthy subjects shows that important information 
relating to vascular stiffness and hence cardiovascular risk can be obtained 
from 
the DVP. This will need to be verified in a prospective outcome study. 
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In conclusion, the DVP contains similar information to the pressure pulse. 
It is influenced by characteristics of the systemic circulation. The DVP is a 
potentially useful tool for the rapid analysis of arterial structure and function. 
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CHAPTER 10: Appendices 
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10.1 Algorithm to calculate the average pulse 
10.1.1 Overview 
This algorithm is used on the DVP or pressure signal to calculate the 
average pulse. First, the foot of the pulses are detected. Individual pulses are 
nonnalised to calculate the average pulse. 
10.1.2 Detection of the foot of the pulses 
04 points averaging process of the signal to reduce electrical noise (optional) 
0 Calculation of the I st derivative of the signal (derv) 
0 Detection of the maximum value of the signal (MaxDerv) 
0 Calculation of a threshold: Thres = MaxDerv*0.6 
0 Test on every samples if derv(i) > Thres. If true, then a new pulse is 
identified and the zero crossing of the I st derivative before that is the foot of 
the pulse (see figure 54). 
0 By processing the entire signal, an array containing the time of the foot of 
each pulse is obtained. 
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DVP signal 
1 sl derivative 
0 
derv(i) > Thres 
-- threshold 
zero-crossing b; fore 
threshold crossing 
foot of the pulse 
figure 54. - Detection of thefoot of the pulse 
10.1.3 Obtaining the averaged pulse 
0A pulse is defined as the signal between 2 consecutive feet 







figure 55: Removal of the DC "drift" component 
0 Period nonnalisation by interpolation (linear interpolation is sufficient 
because there is little difference between the original duration of the pulse 
and the normalised period) (figure 56). 
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figure 57: Amplitude normalisation 
Normalised pulses are ensemble averaged. 
figure 58: Ensemble averaging ofpulses (average pulse in blue) 
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10.2 Calculation of RI from the DVP 
10.2.1 Definition of RI 
RI = b/a x 100 
figure 59: Definition ofRI 
10.2.2 Algorithm 
Calculation of the I st derivative of the pulse (derv) 
0 Find of the maximum value and time of the pulse (maxpulse, maxpos) 
0 Identification of the time (tinf) of the maximum of the I st derivative in the 
(. 6 search window" (inflection point). The "search window" is set to be after 
the max of the pulse and shorter than the full length of the pulse. 
0 If derv[ti,, d is <0, then this identifies an inflection point and there is no 
second peak (as in case 2, figure 60). Therefore RI = DVP[ti,, d/ maxpulse 
0 If DVP[ti,, f] is >0 (case 1, figure 60), then the next zero-crossing point of 
derv is identified. This occurs at the time of the 2 nd peak. Therefore 








figure 60. - Determination of the notch to calculate RI 
As described in section 6.5.2 and figure 40, DVP waveforms such as in 
the above case I would usually be found in young healthy volunteers. With 
aging, the DVP waveform changes to a contour like the one shown in case 2. In 
subjects with especially stiff arteries, it is possible that no peak or inflection point 
is present. On the waveforms obtained for this thesis, less than 1% of the traces 
had no peak/inflection point and hence were not analysable. It is, however, 
imPortant to note that very few subjects aged more than 75years old were studied 






10.3 Calculation of SI from the DVP 
10.3.1 Definition of SI 
PPT 
Case 2: shoulder 
before the peak 
PPT 
Case 1 
Sl = subject height / PPT 
figure 61. - Definition of SI 
Sl is defined as the height of the subject divided by the time between the 
2 peaks, the peak to peak time (PPT). 
PPT = T2 - T, 
where T, = maxpos ortshoulder (see following case I and 2) 




(as described in section 10.2.2) 
9 Find of the maximum of the DVP (maxpulse, maxpos) 




Calculate the peak to peak time, PPT = (ti,, f - maxpos)/Fs with Fs being the 
sampling frequency 
Calculate SI from the subject height. SI = height / PPT 
Case 2: Shoulder before the peak 
Here there are 2 cases, the shoulder could be a inflection point (case 2a) or a 
peak (case 2b). In both case the notch is detennined as described in the section 
10.2 (timing of the notch: tinf). 
Case 2a Case 2b 
figure 62: Determination ofPPT 
So the algorithm is as follows: 
0 Find of the max of the pulse (maxpulse, maxpos) 
0 Find the time of the inflection point as described in the section 
10.2(tinf) 
0 Find the maximum of the derivative (abscissa: dervmaxpos) 




0 If there is a (or 2) zero-crossing(s), we are in the case 2b and the abscissa of 
the shoulder is the zero-crossing point the nearest to tinf (abscissa: tshoulder)- 
0 If there is no zero-crossing, we are in case 2a. The local minimum need to be 
find. It can be find by using the 2 second zero-crossing of the 2 nd derivative 
before ti,, f (abscissa: tshoulder). 
0 Calculate the peak to peak time, PPT =(tinf - tshoulder)/Fs (or PPT= (tpeak - 
tshoulder)/Fs) with Fs being the sampling frequency 
Calculate SI from the subject height. SI = height / PPT 
10.3.3 Accuracy of the SI measurement 
SI is calculated from subject height and PPT and there error in SI will 
come mainly form the estimation of PPT. The process of linear interpolation to 
obtain an average pulse (section 10.1.3) gives a "sampling frequency" of 
150*HR/60 (where HR is heart rate in beats per minute). So for the averaged 
pulse, the error in estimating PPT is 1/(2.5*HR)/2 seconds (sampling period 
divided by 2). For HR = 40 bpm, the error in estimating PPT would be ±5ms, for 
HR = 60 bpm, ±3ms and for HR = 100 bpm, ±2ms. 
In section 6.5.2, SI was measured in 87 asymptornatic subjects. In this 
cohort the slowest HR was 36 bpm and the lowest PPT value was II 8ms (not on 
the same subject). So in the worst scenario, the error in PPT is ±5.5ms 
representing an error of ±4.7% in PPT and an error of ±4.6% in Sl (see 
calculation details below). This is however the worst case scenario, in the same 
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cohort, the mean HR was 67bpm and PPT 21 gms which gives an error of ± 1.4% 
in estimating SI. 
Calculation to evaluate the error in estimating SI: 
The error in estimating PPT is: err =1x1 2 2.5 x HR 
The error on Sl in % is: (H being the subject height): 
HH 





PPT x err 
2H PPT 2- err 2 
PPT 
10.4 Volume / Pressure Transfer Function 
This appendix relates to the method to derive the DVP to pressure 




There are several methods to evaluate TF. The one used in chapter 2 is 
based on frequency domain analysis of the average pulses. Determinations of the 
TF were perfon-ned using with Matlab 5.2. 
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10.4.1 Determining the TF for each individual 
The DVP and the pressure pulse (radial and/or digital) were measured 
simultaneously for at least 6 consecutive heart beats. First, the average DVP 
(Vpulse) and the average pressure pulse (Ppulse) were calculated as described in 
appendix 10.1. After this algorithm, Vpulse and Ppulse were both time 
normalised to have a fixed duration of 150 samples independent of the HR. 
A discrete Fourier transform was performed using the in-built fast Fourier 
transform(FFT) function of Maltab. This function can perfonn a discrete FFT on 
a signal, irrespective of the number of samples. If the number of samples is a 
power of two, a fast radix-2 fast-Fourier transforrn algorithm is used. If the 
length of the signal is not a power of two, a slower algorithm is employed. The 
only difference is the computing time. With the performance of the computer 
used for this analysis and the size of input signals (Vpulse and Ppulse), 
computing time was not an issue and so the FFT was performed on 150 points. 
Therefore the output of the FFT was on 150 points. The I" sample representing 
the mean of the signal, the 2 nd sample the fundamental and the 3 rd sample the I" 
harmonic and so on. In the rest of the text, the mean, the fundamental and the 
harmonics will be refer as "harmonics". For a signal from a subject whose HR is 
60bpm, the 10 first harmonics of the FFT represents the FFT from 0 to 1 OHz. For 
a subject whose HR is 120bpm, it represents the FFT from 0 to 20 Hz. A TF for 
each subject can be computed by dividing the 10 first harmonics of FFT(Ppulse) 
by the 10 first hannonics of FFT(Vpulse). 
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10.4.2 Averaging individual TF 
With the above method, applying an FFT to a single pulse, an individual 
TF (ITF) is obtained for each subject. It is represented by an array of complex 
numbers corresponding to the harmonics of the wavefon-n. Because the period of 
the pulse has been nonnalised, the frequency of each han-nonic depends on the 
HR. To calculate the general transfer function (GTF), an averaging process needs 
to be applied to the ITFs. Two options were tried: 
averaging the ITF values after interpolation of these to the same frequency. 
2. averaging the ITF values for each hannonics. 
The method used did not significantly change the reconstruction of the pressure 
pulse and therefore option 2 was used as it involves less data manipulation. 
The generalised TF (GTF) was calculating by averaging the amplitude 
and phase of the ITFs. 
Alk exp(- i'(Plk)' 
ITFk 
A2k exp(- i* 92k 











This method gave the smallest SD and the best reconstructed pulse compared to 
an averaging process based on the real and imaginary part. 
10.4.3 Pulse reconstruction 
The pressure pulse was reconstructed from the DVP and then compared 
to the measured pressure pulse. The reconstructed pressure pulse was calculated 
as follows where IFFT stands for Inverse Fast Fourier transfonn. 
Precons= IFFT(GTF - FFT(Vpulse)) 
Vpulse is the average DVP and was computed as described in section 
10.1. So, as described earlier, the Fourier transform of Vpulse is obtained for 
samples corresponding to each harmonics. The GTF was therefore resampled to 
the same number of samples as the pulse using the 10 first harmonics and setting 
values for higher harmonics to 10-6 (equivalent to a low pass filter). 
159 
Bibliography 
1. Anderson TJ. Assessment and treatment of endothelial dysfunction in humans. J Am Co// Cardiol. 1999; 34: 631-638. 
2. Asmar R. Arterial Stiffness and Pulse Wave Velocity: clinical 
applications. Elsevier, 1999. 
3. Asmar RG, London GM, O'Rourke ME et al. Improvement in 
blood pressure, arterial stiffness and wave reflections with a 
very-low-dose perindopril/indapamide combination in 
hypertensive patient: a comparison with atenolol. Hypertension. 
2001; 38: 922-926. 
4. Asmar R. Effect of hypertensive agents on arterial stiffness as 
evaluated by pulse wave velocity. Am J Cardiovasc Drugs. 
2001; 1: 387-397. 
5. Asmar R, Rudchini A, Blacher J et al. Pulse Pressure and aortic 
pulse wave are markers of cardiovascular risk in hypertensive. 
Am J of Hypertension. 2001; 14: 91-97. 
6. Avolio AP. Multi-branched model of the human arterial system. 
Med &Biol &Eng &Comput. 1980; 18: 709-718. 
7. Avolio AP. Ageing and wave reflection. Joumal of Hypertension. 
1992; 1 O: S83-S86. 
8. Avolio AP, Chen S-G, Wang R-P et al. Effects of aging on 
changing arterial compliance and left ventricular load in a 
northern Chinese urban community. Circulation. 1983; 68: 50-58. 
9. Avolio AP, Fa-Quan D, Wei-Qiang L et al. Effects of aging on 
arterial distensibility in populations with high and low prevelance 
of hypertension: comparison between urban and rural 
communities in China. Circulation. 1985; 71: 202-210. 
10. Barker DJ, Bull AR, Osmond C etal. Fetal and placental size and 
risk of hypertension in adult life. BMJ. 1990; 301: 259-262. 
1. Barker DJ, Osmond C. Low birth weight and hypertension. BMJ. 
1988; 297: 134-135. 
12. Barker DJ, Osmond C, Golding J et al. Growth in utero, blood 
pressure in childhood and adult life, and mortality from 
cardiovascular disease. BMJ. 1989; 298: 564-567. 
160 
13. Barker DJ, Winter PD, Osmond C et al. Weight in infancy and death from ischaernic heart disease. Lancet. 1989; 2: 577-580. 
14. Bass A, Walden R, Hirshberg A et al. Pharmacokinetic activity of 
nitrites evaluated by digital pulse volume recording. J Cardiovasc Surg. 1989; 30: 395-397. 
15. Benetos A, Asmar R, Asmar R et al. Arterial stiffness, hydrochlorothiazide and converting enzyme inhibition in essential 
hypertension. Joumal of Human Hypertension. 1996; 10: 77-82. 
16. Blacher J, Asmar R, Djane S et al. Aortic pulse wave velocity as 
a marker of cardiovascular risk in hypertensive patients. 
Hypertension. 1999; 33: 1111-1117. 
17. Blacher J, Guerin AP, Pannier B et al. Impact of aortic stiffness 
an survival in end-stage renal disease. Circulation. 
1999; 99: 2434-2439. 
18. Bland JM, Altman D. Statistical methods for assessing 
agreement between two methods of clinical measurement. The 
Lancet. 1986; 8: 307-310. 
19. Bortolotto LA, Blacher J, Kondo T et al. Assessment of vascular 
aging and atherosclerosis in hypertensive subjects: Second 
derivative of photoplethysmogram versus pulse wave velocity. 
Am J of Hypertension. 2000; 13: 165-17 1. 
20. Boutouyrie P, Tropeano Al, Asmar R et al. Aortic stiffness is an 
independent predictor of primary coronary events in hypertensive 
patients: a longitudinal study. Hypertension. 2002; 39: 10-15. 
21. Bramwell JC, Hill AV. The velocity of the pulse wave in man. 
Proceedings of the Royal Society, London, Ser B. 1922; 93: 298- 
306. 
22. Broadbent WH. The pulse. London: Cassell ed. 1890. 
23. Buschmann M, et al. Comparison of the effects of two different 
galenical preparations of glyceryl trinitrate on pulmonary artery 
pressure and on the finger pulse curve. Eur J Clin Pharmacol. 
1993; 44: 451-456. 
24. Cayatte AJ, Palacino JJ, Horten K et al. Chronic inhibition of 
nitric oxide production accelerates neointima formation and 
impairs endothelial function in hype rchol este rolem ic rabbits. 
Arterioscler Thromb. 1994; 14: 753-759. 
161 
25. Celermajer IDS, Sorensen KE, Gooch VM et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. The Lancet. 1992; 340: 1111-1115. 
26. Channon KM, Qian H, George SE. Nitric oxide synthase in 
atherosclerosis and vascular injury: insights from experimental 
gene therapy. Arterioscler Thromb Vasc Biol. 2000; 20: 1873- 
1881. 
27. Chen C-H, Nevo E, Fetics BJ et al. Estimation of central aortic 
pressure waveform by mathematical transformation of radial 
tonometry pressure. Circulation. 1997; 95: 1827-1836. 
28. Chen C-H, Ting C-T, Nussbacher A et al. Validation of carotid 
artery tonometry as a mean of estimating augmentation index of 
ascending aortic pressure. Hypertension. 1996; 27: 168-175. 
29. Chowienczyk PJ, Kelly RP, MacCallurn H et al. 
Photoplethysmographic assessment of pulse wave reflection: 
blunted response to endothelium-dependent beta2-adrenergic 
vasodilation in type II diabetes mellitus. J Am Coll Cardiol. 
1999; 34: 2007-2014. 
30. Cockcroft JR, McEniery CM, Wilkinson 113. Pseudo hypertension 
of youth: too much of a good thing? Am J Hypertens. 
2003; 16: 262-264. 
31. Cohn JN, Finkelstein SM, McVeigh GE et al. Noninvasive pulse 
wave analysis for the early detection of vascular disease. 
Hypertension. 1995; 26: 503-508. 
32. Cruickshank K, Riste L, Anderson SG et al. Aortic pulse-wave 
velocity and its relationship to mortality in diabetes and glucose 
intolerance: an integrated index of vascular function? Circulation. 
2002; 106: 2085-2090. 
33. Davey DA, MacGillivray 1. The classification and definition of the 
hypertensive disorders of pregnancy. Am J Obstet Gynecol. 
1988; 158: 892-898. 
34. Dawber TR, Thomas HE, Jr., McNamara PM. Characteristics of 
the dicrotic notch of the arterial pulse wave in coronary heart 
disease. Angiology. 1973; 24: 244-255. 
35. Dawes M, Chowienczyk PJ, Ritter JM. Effects of inhibition of the 
L-arginine/nitric oxide pathway on vasodilation caused by beta- 
adrenergic agonists in human forearm. Circulation. 
1997; 95: 2293-2297. 
162 
36. Dillon JB, Hertzman AB. The form of the volume pulse in the finger pad in health, arteriosclerosis, and hypertension. Am Heart J. 1941; 21: 172-190. 
37. Feelisch M. Biotransformation to nitric oxide of organic nitrates in comparison to other nitrovasodilators. Eur Heart J. 1993; 14 Suppl 1: 123-132. 
38. Fetics BJ, Nevo E, Chen C-H et al. Parametric model derivation 
of transfer function for noninvasive estimation of aortic pressure by radial tonometry. IEEE Trans Biomed Eng. 1999; 46: 698-706. 
39. Finkelstein SM, Collins VR, Cohn JN. Arterial vascular 
compliance response to vasodilators by Fourier and pulse 
contour analysis. Hypertension. 1988; 12: 380-387. 
40. Franck 0. Die Grundform des arteriellen Pulses. Erste 
Abhandlung. Mathematische Analyse. Zeitschriff für Biologie. 
1899; 37: 483-526. 
41. Goetz RH. Plethysmography of the skin in the investigation of 
peripheral vascular diseases. Brit J Surg. 1940; 27: 506-520. 
42. Guerin AP, Pannier B, Marchais SJ et al. Effects of 
anti hypertensive agents on carotid pulse contour in humans. 
Journal of Human Hypertension. 1992; 6: S37-S40. 
43. Hallock P. Arterial elasticity in man in relation to age as 
evaluated by the pulse wave velocity method. Arch Inter Med. 
1934; 54: 770-798. 
44. Hannemann RE, Stoltman WIP, Bronson EC et al. Digital 
plethysmography for assessing erythrityl tetranitrate 
bioavailability. Clinical Pharma Ther. 1981; 35-39. 
45. Hashimoto J, Chonan K, Aoki Y et al. Pulse wave velocity and 
the second derivative of the finger photoplethysmogram in 
treated hypertensive patients: their relationship and associating 
factors. J Hypertens. 2002; 20: 2415-2422. 
46. Haynes F, Ellis LB, Weiss S. Pulse wave velocity and arterial 
elasticity in arterial hypertension, arteriosclerosis and related 
conditions. Am Heart J. 1936; 11: 385-401. 
47. Hayward CS, Kraidly M, Webb CM et al. Assessment of 
endothelial function using peripheral waveform analysis: a clinical 
application. J Am Coll Cardiol. 2002; 40: 521-528. 
163 
48. Hertzman AB. The blood supply of various skin areas as estimated by the photoelectric plethysmograph. Am J Physiol. 1939; 124: 328-340. 
49. Huxley R, Neil A, Collins R. Unravelling the fetal origins hypothesis: is there really an inverse association between birthweight and subsequent blood pressure? Lancet. 2002; 360: 659-665. 
50. Huxley RR, Shiell AW, Law CM. The role of size at birth and 
postnatal catch-up growth in determining systolic blood pressure: 
a systematic review of the literature. J Hyperfens. 2000; 18: 815- 
831. 
51. Ignarro LJ, Buga GM, Wood KS et al. Endothelium-derived 
relaxing factor produced and released from artery and vein is 
nitric oxide. Proc Natl Acad Sci USA. 1987; 84: 9265-9269. 
52. Imanaga 1, Hara H, Koyanagi S et al. Correlation between wave 
components of the second derivative of plethysmogram and 
arterial distensibility. Jpn Heart J. 1998; 39: 775-784. 
53. Imholz BPM, Wieling W, Van Montfrans Ga et al. Fifteen years 
experience with finger arterial pressure monitoring; assessment 
of the technology. Cardiovasc Res. 1998; 38: 605-616. 
54. Kannel WB, Dawber TR, McGee DL. Perspectives on systolic 
hypertension. The Framingham study. Circulation. 1980; 61: 1179- 
1182. 
55. Karamanoglu M, Feneley MP. On-line synthesis of the human 
ascending aortic pressure pulse from the finger pulse. 
Hypertension. 1997; 1416-1424. 
56. Karamanoglu M, Gallagher DE, Avolio AP et al. Functional origin 
of reflected pressure waves in a multibranched model of the 
human arterial system. Am J Physiol. 1994; 267: H 1681 -H 1688. 
57. Karamanoglu M, Gallagher DE, Avolio AP et al. Pressure wave 
propagation in a multibranched model of the human upper limb. 
Am J Physiol. 1995; 269: H1 363-H 1369. 
58. Karamanoglu M, O'Rourke MF, Avolio AP et al. An analysis of 
the relationship between central aortic and peripheral upper limb 
pressure waves in man. European Heart Joumal. 1993; 14: 160- 
167. 
59. Kelly RP, Gibbs H, O'Rourke MF et al. Nitroglycerin has more 
favourable effects on left ventricular afterload than apparent from 
164 
measurement of pressure in a peripheral artery. European Heart Journal. 1990; 11: 138-144. 
60. Kelly RP, Hayward C, Avolio AP et al. Noninvasive determination 
of age-related changes in the human arterial pulse. Circulation. 1989; 80: 1652-1659. 
61. Kelly RIP, Hayward C, Ganis J et al. Noninvasive registration of the arterial pressure pulsewave for measuring high-fidelity 
applanation tonometry. J Vasc Med Biol. 1989; 1: 142-149. 
62. Kelly RIP, Hayward C, Winter D et al. Non-invasive determination 
of ageing changes in the arterial pulse. FASEB Joumal. 1988; 2. 
63. Kelly RIP, Karamanoglu M, Gibbs H et al. Noninvasive carotid 
pressure wave registration as an indicator of ascending aortic 
pressure. J Vasc Med Biol. 1989; 1: 241-247. 
64. Kelly RP, Millasseau SC, Ritter JM et al. Vasoactive drugs 
influence aortic augmentation index independently of pulse-wave 
velocity in healthy men. Hypertension. 2001; 37: 1429-1433. 
65. Klemsdal TO, Andersson TLG, Matz J et al. Vitamin E restores 
endotheliurn dependent vasodilatation in cholesterol fed rabbits: 
in vivo measurements by photoplethysmography. Cardiovasc 
Res. 1994; 28: 1-6. 
66. Korteweg DJ. Über die Fortpflanzungsgesschwindigkeit des 
Schalles in elastischen Rohren. Annals of Physics and Chemistry 
(NS). 1878; 5: 520-537. 
67. Kuhlencordt PJ, Gyurko R, Han F et al. Accelerated 
atherosclerosis, aortic aneurysm formation, and ischernic heart 
disease in apolipoprotein E/endothelial nitric oxide synthase 
double-knockout mice. Circulation. 2001; 104: 448-454. 
68. Latham RD, Westerhof N, Sipkema P et al. Regional wave travel 
and reflections along the human aorta: a study with six 
simultaneous micromanometric pressures. Circulation. 
1985; 72: 1257-1269. 
69. Laurent S, Boutouyrie P, Asmar R et al. Aortic stiffness is an 
independent predictor of all-cause and cardiovascular mortality in 
hypertensive patients. Hypertension. 2001; 37: 1236-1241. 
70. Law CM, Shiell AW. Is blood pressure inversely related to birth 
weight? The strength of evidence from a systematic review of the 
literature. J Hypertens. 1996; 14: 935-941. 
165 
71. Lax H, Feinberg A, Cohen BM. Studies of the arterial pulse wave 
and its modification in the presence of human arteriosclerosis. J Chronic Dis. 1956; 3: 618-631. 
72. Lehmann ED, Hopkins KD, Rawesh A et al. Relation between 
number of cardiovascular risk factors/events and non-invasive Doppler ultrasound assessments of aortic compliance. 
Hypertension. 1998; 32: 565-569. 
73. Liang Y-L, Teede H, Kotsopoulos D et al. Non-invasive 
measurements of arterial structure and function; repeatability, 
interrelationships and trial sample size. Clin Sci. 1998; 95: 669- 
679. 
74. Lind L, Hall J, Johansson K. Evaluation of four different methods 
to measure endothelium-dependent vasodilation in the human 
peripheral circulation. Clin Sci (Lond). 2002; 102: 561-567. 
75. Lind L, Pettersson K, Johansson K. Analysis of enclothelium- 
dependent vasodilation by use of the radial artery pulse wave 
obtained by applanation tonometry. Clin Physiol Funct Imaging. 
2003; 23: 50-57. 
76. London GM, Blacher J, Pannier B et al. Arterial wave reflections 
and survival in end-stage renal failure. Hypertension. 
2001; 38: 434-438. 
77. London GIVI, Guerin AP, Pannier B et al. Increased systolic 
pressure in chronic uremia, role of arterial wave reflections. 
Hypertension. 1992; 20: 10-19. 
78. Lund F. Digital pulse plethysmography (DPG) in studies of the 
hemodynamic response to nitrates -A survey of recording 
methods and principles of analysis. Acta Pharmacol Toxicol. 
1986; 59: 76-86. 
79. Mackensie J. The study of the pulse. Arterial, venous and hepatic 
and of the movements of the heart. Edinburg: Pentland ed. 
1902. 
80. Mahmud A, Feely J. Spurious systolic hypertension of youth: fit 
young men with elastic arteries. Am J Hypertens. 
2003; 16: 229- 
232. 
81. Mahmud A, Feely J. Acute effect of Caffeine on Arterial stiffness 
and aortic pressure waveform. Hypertension. 
2001; 38: 227-231. 
82. Mahomed FA. The Physiology and clinical use of the 
sphygmograph. Medical Times and Gazette, 
London. 1872; 1: 62- 
65. 
166 
83. Mahomed FA. The aetiology of Bright's disease and the prealburninuric stage. Med Chir Trans. 1874; 57: 197-228. 
84. Mahomed FA. On the sphygmographic evidence of arterio- 
capillary fibrosis. Trans Pathlo Soc. 1877; 28: 393-397. 
85. Martin H, Hu J, Gennser G et al. Impaired endothelial function 
and increased carotid stiffness in 9-year-old children with low birthweight. Circulation. 2000; 102: 2739-2744. 
86. Martyn CN, Barker DJ, Jespersen S et al. Growth in utero, adult blood pressure, and arterial compliance. Br Heart J. 
1995; 73: 116-121. 
87. McDonald DA, Taylor MG. The hydrodynamics of the arterial 
circulation. Progress in Biophysics and Chemistry. 1959; 9: 107- 
173. 
88. McVeigh GE, Bratteli CW, Morgan DJ et al. Age-Related 
Abnormalities in Arterial Compliance Identified by Pressure Pulse 
Contour Analysis: Aging and Arterial Compliance. Hypertension. 
1999; 33: 1392-1398. 
89. McVeigh GE, Morgan DJ, Finkelstein SM et al. Vascular 
abnormalities associated with long-term cigarette smoking 
identified by arterial waveform analysis. Am J of Medecine. 
1997; 102: 227-231. 
90. Meaume S, Benetos A, Henry OF et al. Aortic pulse wave 
velocity predicts cardiovascular mortality in subjects >70 years of 
age. Arterioscler Thromb Vasc Biol. 2001; 21: 2046-2050. 
91. Miyai N, Miyashita K, Arita M et al. Noninvasive assessment of 
arterial distensibiliy in adolescents using the second derivative of 
photoplethysmogram waveform. Eur J Appl Physiol. 
2001; 86: 119-124. 
92. Moens Al. Die Pulskurve. Leiden ed. 1878. 
93. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, 
pathophysiology, and pharmacology. Pharmacol Rev. 
1991; 43: 109-142. 
94. Morikawa Y. Characteristic pulse wave caused by organic 
nitrates. Nature. 1967; 841-842. 
95. Morikawa Y, Matsuzaka J, Kuratsune M et al. Plethysmographic 
study of effects of alcohol. Nature. 1968; 220: 186-187. 
167 
96. Müller 0, Weis E. Ober die Topographie, die Entstehung und die Bedeutung des menschlichen Sphygmogramms. Deutsches Arch f klin Med. 1911; 105: 321. 
97. Murgo, JP, Westerhof N, Giolma JP et al. Aortic input impedance in normal man: relationship to pressure waveforms. Circulation. 1980; 63: 105-116. 
98. Murrell W. Nitro-glycerine as a remedy for angina pectoris - part 1- The Lancet. 1879; 80: 80-81. 
99. Murrell W. Nitro-glycerine as a remedy for angina pectoris - part 2. The Lancet. 1879; 80: 113-115. 
100. Murrell W. Nitro-glycerine as a remedy for angina pectoris - part 3. The Lancet. 1879; 80: 151-152. 
101. Murrell W. Nitro-glycerine as a remedy for angina pectoris - part 4. The Lancet. 1879; 80: 225-226. 
102. Napoli C, Ignarro U. Nitric oxide and atherosclerosis. Nitric 
Oxide. 2001; 5: 88-97. 
103. Naruse K, Shimizu K, Muramatsu M et al. Long-term inhibition of 
NO synthesis promotes atherosclerosis in the 
hypercholesterolemic rabbit thoracic aorta. PGH2 does not 
contribute to impaired endothelium-dependent relaxation. 
Atterioscler Thromb. 1994; 14: 746-752. 
104. Nichols WW, O'Rourke MF McDonald's blood flow in arteries. 
Theoretical, experimental and clinical principles. Oxford 
University Press, Inc, New York, 1999. 
105. O'Brien E, Petrie J, Littler W et al. An outline of the revised 
British Hypertension Society protocol for the evaluation of blood 
pressure measuring devices. J Hypertens. 1993; 11: 677-679. 
106. O'Brien E, Petrie J, Littler W et al. The British Hypertension 
Society protocol for the evaluation of automated and semi- 
automated blood pressure measuring devices with special 
reference to ambulatory systems. J Hypertens. 1990; 8: 607-619. 
107. O'Rourke MF, Pauca A, Jiang XJ. Pulse wave analysis. BrJ Clin 
Pharmacol. 2001; 51: 507-522. 
108. O'Rourke MF, Vlachopoulos C, Graham RM. Spurious systolic 
hypertension in youth. Vasc Med. 2000; 5: 141-145. 
168 
109. O'Rourke MF. Pressure and flow waves in systemic arteries and the anatomical design of the arterial system. J Appl Physiol. 1967; 23: 139-149. 
110. O'Rourke MF, Avolio AP. Pulsatile flow and pressure inhuman 
systemic arteries: studies in man and in a multi-branched model 
of the human systemic arterial tree. Circ Res. 1980; 46: 363-372. 
1. O'Rourke MF, Kelly RP, Avolio AP. The arterial pulse. 
Philadelphia: Lea & Febiger ed. 1992. 
112. O'Rourke MF, Mancia G. Areterial stiffness. Journalof 
Hypertension. 1999; 17: 1-4. 
113. Osmond C, Barker DJ, Slattery JM. Risk of death from 
cardiovascular disease and chronic bronchitis determined by 
place of birth in England and Wales. J Epidemiol Community 
Health. 1990; 44: 139-141. 
114. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release 
accounts for the biological activity of endothelium-derived 
relaxing factor. Nature. 1987; 327: 524-526. 
115. Pauca AL, O'Rourke MF, Kon ND. Prospective evaluation of a 
method for estimating ascending aortic pressure from the radial 
artery pressure waveform. Hypertension. 2001; 38: 932-937. 
116. Pefi6z J. Photoeletric measurement of blood pressure, volume 
and flow in the finger. Digest 10th Int Conf Med Biol Eng p104, 
Dresden, Germany. 1973. 
117. Perticone F, Ceravolo R, Pujia A et al. Prognostic significance of 
endothelial dysfunction in hypertensive patients. Circulation. 
2001; 104: 191-196. 
118. Poston L. Maternal vascular function in pregnancy. J Hum 
Hypertens. 1996; 10: 391-394. 
119. Quan H, Shih WJ. Assessing reproducibility by the within-subject 
coefficient of variation with random effects models. Biometrics. 
1996; 52: 1195-1203. 
120. Rang HP, Dale MM, Ritter JM et al. Pharmacology. 2003. 
121. Safar ME. Editorial review: Pulse pressure in essential 
hypertension: clinical and therapeutical implications. Joumal of 
Hypertension. 1989; 7: 769-776. 
169 
122. SchachingerV, Britten MB, ZeiherAM. Prognostic impact of 
coronary vasodilator dysfunction on adverse long-term outcome 
of coronary heart disease. Circulation. 2000; 101: 1899-1906. 
123. Schinz A, Gottsauner A, Schnelle K. Digital pulse 
plethysmography: a sensitive test of the pharmacodynamics of 
nitrates - reproducibility and quantitation of the technique. Nitrate 
111. Kardiovaskulare Wirkungen. 1999: 117-122. 
124. Segers P, Carlier S, Pasquet A et al. Individualizing the aorto- 
radial pressure transfer function: feasibility of a model-based 
approach. Am J Physiol. 2000; 279: H542-H549. 
125. Segers P, Qasem A, De Backer T et al. Peripheral "oscillatory" 
compliance is associated with aortic augmentation index. 
Hypertension. 2001; 37: 1434-1439. 
126. Siebenhofer A, Kemp C, Sutton A et al. The reproducibility of 
central aortic blood pressure measurements in healthy subjects 
using applanation tonometry and sphygmocardiography. J Hum 
Hypertens. 1999; 13: 625-629. 
127. Soderstrom S, Nyberg G, O'Rourke MF et al. Can a clinically 
useful aortic pressure wave be derived from a radial pressure 
wave? Br J Anaesth. 2002; 88: 481-488. 
128. Stengele E, Winkler F, Trenk D et al. Digital pulse 
plethysmography as a non-invasive method for predicting drug- 
induced changes in left ventricular preload. EurJ Clin 
Pharmacol. 1996; 50: 279-282. 
129. Sugimachi M, Kawada T, Shishido T et al. Estimation of arterial 
mechanical properties from aortic and tonometric arterial 
pressure waveforms. Methods of information in medecine. 
1997; 36: 250-253. 
130. Suwaidi JA, Hamasaki S, Higano ST et al. Long-term follow-up of 
patients with mild coronary artery disease and endothelial 
dysfunction. Circulation. 2000; 101: 948-954. 
131. Takada H, Washino K, Harrell JS et al. Acceleration 
plethysmography to evaluate aging effect in cardiovascular 
system. Medical Progress through Technology. 
1997; 21: 205- 
210. 
132. Takazawa K, Fujita M, Yabe K et al. Clinical usefulness of 
the 
second derivative of a plethysmogram 
(acceleration 
plethysmogram). Journal of Cardiology. 
1993; 23: 207-217. 
170 
133. Takazawa K, Tanaka N, Fujita M et al. Assessment of vasoactive 
agents and vascular aging by second derivative of the 
photoplethysmograph waveform. Hypertension. 1998; 32: 365- 
370. 
134. Taylor MG. An experimental determination of the propagation of fluid oscillations in a tube with a visco-elastic wall; together with 
an analysis of hte characteristics required in an electrical 
analogue. Phys Med Biol. 1959; 4: 63-82. 
135. Taylor MG. The input impedance of an assembly of randomly 
branching elastic tubes. Biophysical Joumal. 1966; 6: 29-51. 
136. Ting C-T, Chen C-H, Chang M-S et al. Short- and long-term 
effects of anti hypertensive drugs on arterial reflections, 
compliance, and impedance. Hypettension. 1995; 26: 524-530. 
137. U. S. Department of health and human services. National high 
blood pressure education program (NHBPEP). Working group 
report on high blood pressure in pregnancy. National Institutes of 
Health Publication, editor. 91,3029.1991. 
138. Vlachopoulos C, Hirata K, O'Rourke MF. Effect of caffeine on 
aortic elastic properties and wave reflection. J Hypertens. 
2003; 21: 563-570. 
139. Wagner F, Siefert F, Trenk D et al. Relationship between 
pharmacolkinetics and hemodynamic tolerance to isosorbibe-5- 
mononitrate. EurJ Clin Pharmacol. 1990; 38: S53-S59. 
140. Weinberg PD, Habens F, Kengatharan M et al. Characteristics of 
the pulse waveform during altered nitric oxide synthesis in the 
rabbit. Br J Pharmacol. 200 1; 133: 361-370. 
141. Westerbacka J, Wilkinson IB, Cockcroft JR et al. Diminished 
Wave Reflection in the Aorta. A Novel Physiological action of 
insulin on large Blood Vessels. Hypertension. 1999; 33: 1118- 
1122. 
142. Whitney RJ- The measurement of volume changes in human 
limbs. J Physiol (London). 1953; 121: 1-27. 
143. Wilkinson 113, Franklin SS, Hall IR et al. Pressure amplification 
explains why pulse pressure is unrelated to risk in young 
subjects. Hypertension. 2001; 38: 1461-1466. 
144. Wilkinson 113, Hall IR, MacCallum H et al. Pulse-wave analysis: 
clinical evaluation of a noninvasive, widely applicable method 
for 
assessing endothelial function. Arterioscler Thromb 
Vasc Biol. 
2002; 22: 147-152. 
171 
145. Wilkinson 113, Prasad K, Hall IR et al. Increased central pulse 
pressure and augmentation index in subjects with 
hypercholesterolemia. J Am Coll Cardiol. 2002; 39: 1005-1011. 
146. Wilkinson 113, Cockcroft JR, Webb DJ. Pulse wave analysis and 
arterial stiffness. J Cardiovascular Pharmacology. 1998; 32- 
suppl. 3: S33-S37. 
147. Wilkinson 113, Fuchs SA, Jansen IM et al. Reproducibility of pulse 
wave velocity and augmentation index measured by pulse wave 
analysis. Journal of Hypertension. 1998; 16: 2079-2084. 
148. Wilkinson 113, MacCallum H, Flint L et al. The influence of heart 
rate on augmentation index and central arterial pressure in 
humans. Joumal of Physiology. 2000; 525: 263-270. 
149. Wilkinson IB, MacCallum H, Hupperetz PC et al. Changes in the 
derived central pressure waveform and pulse pressure in 
response to angiotensin 11 and noradrenaline in man. Joumal of 
Physiology. 2001; 530: 541-550. 
150. Wilkinson 113, MacCallum H, Rooijmans DIF et al. Increase 
augmentation index and systolic stress in type 1 diabetes 
mellitus. QJM. 2000; 93: 441-448. 
151. Wolzt M, Schmetterer L, Rheinberger A et al. Comparison of 
non-invasive methods for the assessment of haemodynamic drug 
effects in healthy male and female volunteers: sex differences in 
cardiovascular responsiveness. Br J Clin Pharma. 1995; 39: 347- 
359. 
152. Womersley JR. Oscillatory flow in arteries: the constrained 
elastic tube as a model of arterial flow and pulse transmission. 
Phys Med Biol. 1957; 2: 178-187. 
153. Yasmin, Brown MJ. Similarities and differences between 
augmentation index and pulse wave velocity in the assessment 
of arterial stiffness. QJM. 1999; 92: 595-600. 
154. Zobel LR, Finkelstein SM, Carlye PF et al. Pressure pulse 
contour analysis in determining the effect of vasodilator drugs on 
vascular hemodynamic impedance characteristics in dogs. Am 
Heart J. 1980; 100: 81-88. 
172 
